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Abstract 
Determination of the anteroposterior axis of a Drosophila embryo depends 
on the asymmetric localization of two maternal morphogens, bicoid {bcd) and 
nanos {nos), to the opposing poles of the egg. The RNAs of bcd and nos are 
localized at the anterior end and the posterior end of the egg, respectively, and are 
translated into two morphogen gradients which initiate and define the cell fates 
along the anteroposterior axis of the embryo. The localization ofbcd mRNA begins 
at oogenesis and depends on several factors. The maternal gene exuperantia {exu) 
encodes a protein which is absolutely required for the localization o f bcd mRNA. 
By molecular genetic analysis, the functional significance of several regions of the 
coding sequence of exu has been analyzed. A region that comprises 62 amino acid 
residues near the C-terminus was found to be dispensable for function. On the 
contrary, several regions were potentially important, as removal o f these regions 
resulted in loss of the localization. Deletions of the regions affected different stages 
of the localization, suggesting the possibility of multiple functional domains 
directing different steps of the localization. Besides, exu protein displayed a spatial 
and temporal localization and the localization at the oocytes of early egg chambers 
seemed to be critical for localization of bcd mRNA. 
Microtubules are required for the localization of exu protein. Localization of 
exu protein was disrupted in the presence of microtubule-destabilizing drugs, 
strongly suggesting interactions between exu protein and microtubules. Their 
interactions were confirmed by cosedimentation experiments. Exu protein was 
found to sediment in the presence of microtubules and thus can be classified, by 
definition, as a microtubule associated protein (MAP). Nonetheless, the interaction 
was specific to only one of the isoforms of exu protein - one of the hypo-
phosphorylated isoforms was cosedimented with microtubules. Results led to a 
proposed function of exu protein which acts as a MAP and its functions might 
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1.1 The formation of body axes 
Development o f an egg into an elaborate multi-cellular organism is a 
universal challenge to most living organisms. It involves cell division as well as 
accurate and precise determination of different cell fates within the embryo. 
Although different classes of animals display a wide range of diversities in their 
body forms, sizes and morphologies, they all share one common feature - they all 
have two fundamental body axes, the anteroposterior and the dorsoventral axes 
(Figure 1.1). Nonetheless, with the exception o f Drosophila, the mechanism of 
body axes formation remains unclear in most of the organisms. In most dipterans, 
including Drosophila, the first step for development is establishment o f body axes 
which allow subsequent developmental events to take place. 
In Drosophila, the two body axes are established by asymmetric localization 
of signals in the embryo (Figure 1.2). The anterior determinant, bicoid {bcd) 
mRNA, and the posterior determinant, nanos {nos) mRNA are localized to two 
opposing poles of the embryo to define the anteroposterior axis. For determination 
of the dorsoventral axis, a ventral signal is produced at the ventral perivitelline 
space to provide polarity for the axis. Establishment of the two body axes was once 
thought to be initiated independently (St. Johnston and Nusslein-Volhard, 1992) but 
it is now considered to originate initially from a single signaling pathway. The 
signaling pathway depends on communications between both the germ cell and 
somatic cells of the egg chambers (reviewed by Anderson, 1995; Lehmann, 1995). 
During early oogenesis, an oocyte is produced by four synchronous cell divisions of 
a stem cell in the germarium with incomplete cytokinesis, in which actin-rich 
intercellular bridges, or ring canals, connect the posteriorly located oocyte and the 
remaining fifteen nurse cells (Figure 1.3). The ring canals allow transportation of 
the necessities for development from the nurse cells to the oocyte, whereas 
transcription is inactive. The oocyte-nurse cell cluster is covered by a layer of 
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Figure 1.3 Formation of developing eggs from the germarium. 
A. Oogenesis begins in region 1 (B), with the division of a germline stem cell 
(S) to produce a cystoblast (Cb) and regenerate a stem cell. The cystoblast 
then divides by four synchronous cell divisions (M l -M4) with incomplete 
cytokinesis into a 16-cell cyst in which cells are interconnected with actin-
rich ring canals. One of the two cells (the black ones) with four ring canals 
adopts the cell fate of oocyte and takes a posterior position within the egg 
chamber. B. The oocyte is developed into a mature egg in a process called 
oogenesis which can be divided into different stages (King, 1970; Mahowald 
and Kambysellis, 1980; Spradling, 1993). Mature eggs are fertilized and 
hatched as embryos at the end of oogenesis. (Adapted from Cooley and 
Theurkarf, 1994) 
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somatic follicle cells which provide an asymmetry to the oocyte, where it is in 
contact wi th the nurse cells at the anterior on the one end and with the follicle cells 
at the posterior on the other end. 
As the oocyte grows, a microtubule-organizing center (MTOC) located at 
the posterior pole of the oocyte extends microtubules into the nurse cells 
(Theurkauf et al., 1992, 1993; reviewed by Cooley and Theurkauf, 1994; St 
Johnston, 1995) (Figure 1.4). This microtubule network allows transportation of 
RNA and protein molecules, from the nurse cells to the oocyte, presumably via 
minus end-directed motors. At mid-oogenesis, there is a reorganization of polarity 
of microtubules in which the posterior MTOC degenerates and microtubules 
nucleates at the anterior pole of the oocyte. This reorganization, which is critical for 
the body axis specification, requires a signal from the posterior follicle cells. The 
transforming growth factor a (TGFa) homologue, giirken, and the epidermal 
growth factor receptor homologue, DER/top, are thought to provide the signal 
(Gonzalez-Reyes et al., 1995; Roth et al., 1995; reviewed by Lehmann, 1995; 
Anderson, 1995). During early stages, the gurken RNA accumulates between the 
oocyte nucleus and the posterior pole, and the synthesis o f gurken protein is 
thought to activate the DER7TOP receptor tyrosine kinase in the follicle cells which 
in turn leads to the expression of posterior polar follicle markers (reviewed by 
Schupbach and Roth, 1994) (Figure 1.5). The two posterior polar follicle cells then 
signal back the oocyte to reorganize the polarity of microtubules. Protein kinase A 
(PKA) in the oocyte is a likely candidate to receive this signal from the follicle cells. 
The activation of PKA may function to destabilize the posterior MTOC and revert 
the polarity of microtubules. In the PKA mutants, failure in reorientation of the 
polarity of microtubules led to mislocalization of the maternal determinants bicoid 
and oskar RNAs (Lane and Kalderon, 1994; reviewed by St. Johnston, 1995; 
reviewed by Anderson, 1995), whose localization at the anterior pole and posterior 
pole, respectively, defines the anteroposterior axis (Frohnh6fer and Nusslein-
Volhard, 1986，1987; Schupbach and Wiechaus, 1986; Lehmann and Nusslein-
Volhard, 1986, 1987; Ephrussi et al., 1991; Kim-Ha et al., 1991). Therefore, the 
reorganization of microtubules is required for determination of the anteroposterior 
axis. 
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Figure 1.4 Microtubule reorganization during oogenesis. 
A. Stage 1 • An MTOC appears to localize at the anterior pole of stage 1 
oocyte near the ring canals. B. Stages 2-6. The MTOC shifts to the 
posterior pole and extends microtubules into adjacent nurse cells. C. Stages 
7-10A. The posterior MTOC is no longer detectable but high concentration 
of microtubules is detected at the anterior cortex of the oocyte. A gradient 
of microtubules is formed from the anterior end to the posterior end of the 
oocyte. D. Stage 10B to 12. Subcortical microtubule bundles assemble and 
ooplasmic streaming begins. The egg chambers are not drawn to scale. 
(Adapted from Theurkaufet al., 1992) 
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Figure 1.5 A model for the initiation of establishment of the two body 
axes by one single signal. 
A. The gurken mRNA is associated with the nucleus which locates at the 
posterior pole of the oocyte at stages 3-6. Its expression induces the follicle 
cells to adopt posterior cell fates. B. The two posterior polar foll icle cells then 
signal back to induce the reorganization of microtubules within the oocyte. C. 
The nucleus as well as the gurken mRNA move along the cortex toward the 
anterior in response to the repolarization of the microtubules. D. Once the 
nucleus reaches the anterior comer of the oocyte, gurken signals the overlying 
follicle cells to adopt dorsal cell fates. Thus the formation two body axes can 
be initiated by one single signal. (Adapted from Anderson, 1995) 
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The reorganization of microtubules is also essential for the establishment of 
the dorsal-ventral polarity. The oocyte nucleus seems to be always associated with 
the minus end of the microtubules (reviewed by Cooley and Theurkauf, 1994) and 
moves from the posterior to the anterior cortex of the oocyte during the 
reorientation o f polarity of microtubules (Figure 1.5) (Gonzalez-Reyes et al., 1995; 
Roth et al., 1995). The gurken mRNA, which remains associated with the oocyte 
nucleus, moves together with the oocyte nucleus to the future anterior-dorsal 
corner of the oocyte and thus defines the dorsal-ventral axis (reviewed by 
Schilpbach and Roth, 1994). The mechanism was thought to involve in the synthesis 
of gurken protein which activates the DER7TOP receptor in the overlying dorsal 
follicle cells. These dorsal follicle cells take a dorsal cell fates and this in turn 
defines the ventral follicle cell fates. The dorsal-ventral polarity is established by the 
activation of the TOLL receptor in the ventral oocyte membrane through the signal 
provided from the ventral follicle cells (reviewed by Morisato and Anderson, 1995). 
1.2 Maternal genes are essential for development 
The reorganization of microtubules allows subsequent localization of the 
maternal signals, bcd RNA and oskar RNA. These signals, which are not originated 
zygotically, are synthesized in somatic nurse cells and deposited to the developing 
egg during oogenesis. The basic organization and polarity of the two main body 
axes are defined and initiated by these signals. Only a small number o f genes (about 
30) have been identified to encode the maternal signals (Nusslein-Volhard et al. 
1987). These genes can be further divided into four groups on the basis of different 
parts of the body axes. One is the dorsoventral group genes which are responsible 
for specifying the dorsoventral axis of the embryo. The other three groups are the 
anterior, posterior and terminal genes which are necessary for defining the 
anteroposterior axis. 
Most of our knowledge on these maternal genes come from the study of 
genetic screens designed to isolate maternal-effect mutations that affect the 
embryonic pattern (Gans et al., 1975; Schupbach and Wieschaus, 1986; Nusslein-
Volhard et al., 1987). Although some of the eggs were normal in shape, the 
embryos produced by maternal-effect mutants showed defects with cuticular 
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pattern. Such defects were accounted as reduction or loss o f some part o f the body 
structure. Mutations in the anterior maternal genes resulted in the loss o f anterior 
head and thoracic structures, while the posterior maternal mutations caused 
deletions of abdominal segments, and the terminal mutations produced defects in 
the unsegmented ends of the embryo, the acron and telson (Figure 1.6). For the 
anteroposterior axis, several mutations, bicoid {hcd)^ exuperantia (exu), swallow 
( 5 w ) , staufen {stau), bicaudal {bic)^ Bicaudal-D {BicD) and Bicaudal-C {BicC) 
(Frohnh6fer and Nusslein-Volhard ,1986, 1987; Schupbach and Weischaus, 1986; 
Gans et al., 1975; Zalokar et al., 1975; Mohler, 1977; Stephenson and Mahowald; 
Nusslein-Volhard, 1977; MohIer and Wieschaus, 1985; reviewed by Nusslein-
Volhard et al., 1987) are responsible for the anterior defects, while oskar {osk), 
vasa (vas), tudor (tud), staufen (stau), valois (vaP), nanos {nos) and pumilio {pum) 
(Lehmann and Nusslein-Volhard, 1986; Schupbach and Weischaus, 1986; Boswell 
and Mahowald, 1985; reviewed by Nusslein-Volhard et al., 1987) affect the 
posterior pattern, and torso、tor\ trunk {trk)^ torsolike {tsP)^ f s ( l ) polehole \fs(l) 
ph] and fs(l) Nasrat {fs(l) N] (Schupbach and Weischaus, 1986; Perrimon et al., 
1986; Degelmann et al., 1986; reviewed by Nusslein-Volhard et al., 1987) 
determines the terminal structures. The mutation stau produces defects in both 
anterior and posterior patterns and is classified into both groups. 
1.3 Maternal gene bicoid is required for formation of anterior 
structures in the embryo 
Mutations in one of the anterior maternal genes, bicoid {bcd), led to loss of 
head and thorax and duplication of telson at the anterior end of the embryos (Figure 
1.7) (Frohnh6fer and Nusslein-Volhard, 1986). Thus hcd is required for formation 
of the anterior pattern. Cytoplasmic transplantation experiments have revealed that 
the activity of bcd is localized at the anterior pole of the embryos (Frohnhofer and 
Nusslein-Volhard, 1986, 1987). This finding was also supported by other 
experimental evidence. For instance, transplantation of cytoplasm from the anterior 
pole of the wild type embryo to the same region of the bcd mutant embryo was 
shown to restore the normal phenotype, while the development of anterior 
structures were observed after the injection of the corresponding cytoplasmic 
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Figure 1.6 Embryonic pattern of maternal mutants. 
Mutations that result in the loss of corresponding body structures. For the 
anterior matemal mutants, head and thoracic structures are lost, while 
abdominal segments are missing in the posterior matemal mutants, and 
unsegmented regions such as acron and telson are deleted in the terminal 
matemal mutants. (A, anterior structures, such as head and thoracic segments; 
P, posterior structures, abdominal segments; T, terminal structures, acron and 
telson; Ac, acron; He, head; Th, thorax; Ab, abdomen; Te, telson) (Adapted 
from St Johnston and Nusslein-Volhard, 1992) 
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Figure 1.7 Defects in the maternal gene mutants. 
In bicoid mutant, the head and thoracic structures are lost and the anterior 
acron is transformed into a telson. In oskar mutant, abdominal segments 
are lost while the acron and telson are missing in the torso mutants. The 
hatched rectangles in the upper row indicates that the normal origin of the 
regions are deleted. The second row shows the corresponding changes in 
the fate maps of the embryo while the lower row shows the cuticle defects 
of the larvae. Ac, acron; Th, thorax; He, head; Ab, abdomen; Te, telson. 
(Adapted from Niisslein-Volhard et al., 1987) 
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homogenate at various positions along the anteroposterior axis of the embryo 
(Frohnh6fer and Nusslein-Volhard, 1986, 1987). 
1.4 Establishment of an anterior to posterior bcd protein 
gradient 
The anterior structure inducing activity present in the cytoplasm of the 
anterior pole was in fact the gene products of bcd. In the embryo, bcd mRNA is 
localized in the cytoplasm at the anterior cortex, and is translated to produce an 
anterior to posterior concentration gradient of bicoid protein, which extends over 
the anterior two-thirds of the embryo (Figure 1.8) (Frigerio et al., 1986; Berleth et 
al., 1988; Driever and Nusslein-Volhard, 1988a; St. Johnston et al., 1989). This 
protein gradient determines the development of anterior structures in a 
concentration dependent manner in which changes in the bcd gene dosage led to 
complementary shifts in both the protein gradient and the anterior fate map (Driver 
and Nusslein-Volhard, 1988b). 
The bcd protein concentration gradient was produced by translation of and 
diffusion of bcd protein from the bcd mRNA source, and degradation of the bcd 
protein throughout the embryo. To produce a stable and nonlinear gradient ofbcd 
protein, the rates of bcd mRNA translation, of diffusion and of dispersed proteolytic 
degradation should reach an appropriate balance (Driever and Nusslein-Volhard, 
1988a). For such a model, bcd protein should have a low stability. The presence of 
several PEST sequences (Driever and Nusslein-Volhard, 1988a), which are present 
in some proteins of short half-life and are thought to be signals for degradation 
(Rogers et al., 1986; Rechsteiner et al., 1987), in bcd protein may reflect its low 
stability. 
1.5 The bcd protein gradient regulates the downstream zygotic 
target genes in a concentration-dependent manner 
Once the concentration gradient of bcd protein has been established in the 
embryo, bcd protein will act as transcriptional activators to regulate the genes 
downstream. In response to the bcd gradient as well as the gradient produced by the 
posterior determinants nanos, a group of zygotic target genes, which determine the 
12 
A 
> ^ “ '^-^=555::^ 
r ^ H K ^ ^ ^ 
^ t ^ H ^ t o : y ) ) 
^ B R � J 
anterior *^^^^ii|^^^^,:、、： ^ ^ ^ ^ ^ ^ ^ ^ posterior 
bcd protein gradient 
: O Z 3 ^ ^ . 
hunchback protein 
Figure 1.8 Expression of bicoid {bcd) and hunchback {hb). 
A. bcd protein gradient is produced by translation of the anteriorly localized 
bcd mRNA and extends over the anterior two-thirds of the embryo. B. 
Translation of homogeneously distributed hb mRNA is activated by bcd 
protein at the anterior while it is inhibited by nanos at the posterior, 
producing uniform distribution of hb protein at the anterior half of the 
embryo. 
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pre-pattern o f the embryo, are spatially expressed along the anteroposterior axis. 
This group of zygotic genes known as gap genes whose mutations result in 
elimination o f particular regions of the embryo and create gap in the 
anterioposterior pattern (Ingham, 1988). Three principle members o f gap genes, 
hunchback, KrUppel, and knirps (Nusslein-Volhard and Wiechaus, 1980) are 
spatially expressed along the embryo from the anterior to posterior to provide the 
first subdivision of the embryo (Knipple et al., 1985; Tautz, 1987, 1988; Gaul et al., 
1987; Pankratz et al., 1989). The gene products of the spatial gene expression 
contain D N A binding finger domains which act as transcriptional regulators. These 
transcriptional regulators further regulate the downstream segmentation genes to 
subdivide the body axis into different regions (Rosenberg et al., 1986; Tautz et al., 
1987; reviewed by Struhl et al., 1989). The gap genes in turn regulate the spatial 
expression of pair-rule genes and segment polarity genes which subdivide the 
embryo into its segmental units which form the segmented pattern of the larvae 
(Figure 1.9). The homeotic genes further specify and direct the development of 
different body parts in segments (reviewed by Ingham, 1988) and thus the cell fates 




1.6 bcd protein acts as transcriptional regulators 
i 
！ The presence of a homeodomain within the bcd protein sequence suggests 
that it is a sequence-specific D N A binding protein and directly regulates zygotic 
target genes (Frigerio et al, 1986; Berleth et al, 1988). One of these target genes 
is the gap gene hunchback {hb\ Tautz et al., 1987) which is required for defining 
structures of thorax and part of the head (Nusslein-Volhard and Wiechaus, 1980; 
Tautz et al., 1987). In response to the bcd protein gradient, hb is expressed 
homogeneously in the anterior half of the embryo with a sharp posterior border 
(Figure 1.8) (Driever et al., 1989; Struhl et al., 1989). The zygotic expression of 
hunchback is directly regulated by the binding of bcd protein. There are five bcd 
protein binding sites within the 300 bp immediately 5，to the start site ofhunchback 
and three of the sites in the promotor region are both required and sufficient for the 
activation of expression of hunchback (Driever and Nusslein-Volhard, 1989a). This 
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half o f the embryo, suggesting that bicoid protein can bind directly to the region and 
activate the transcription of hunchback (Schroder et aL, 1988; Struhl et al., 1989; 
Driever and Nusslein-Volhard, 1989b). 
The gene hunchback is one of the zygotic target genes which are regulated 
by bcd protein. The spatial expression of these genes is regulated by bcd protein in 
concentration-dependent manner. Changes in the maternal bcd gene dosage wil l 
produce complementary shift in both the bcd protein gradient and the spatial 
expression of zygotic target genes (Driever and Nusslein-Volhard, 1989b, Ma et al., 
1996). The bcd protein acts as a morphogen, wi th different threshold concentrations 
defining different anterior cell fates. It regulates the expression of the zygotic target 
genes by binding cooperatively to promoter regions (Struhl et al., 1989; Driever 
and Nusslein-Volhard, 1989b), similar to the binding of lambda repressor to its 
tripartite operator (Johnson et al., 1979; reviewed in Ptashne, 1986; Struhl et al., 
1989). Bcd proteins with multiple D N A binding display positive cooperativity in the 
binding of target DNAs (Ma et al., 1996). In the cooperative binding process, a 
sigmodial binding curve was observed indicating that an on- and off- state of 
I transcription is allowed within a narrow range of bcd protein concentrations 
\ (Driever and Nusslein-Volhard, 1989a, 1989b). In such a model, bcd protein can 
bind multiple binding sites at concentration above certain threshold but cannot bind 
I to any of the sites at a lower concentration at positions slightly more towards the 
posterior. Thus, genes, such as hb, with high affinity bcd binding sites wi l l require 
low bcd concentrations to be activated and expressed in large anterior regions; 
while genes, such as orthodenticle (Finkelstein and Perrimon, 1990), buttonhead 
(Cohen and Jlirgens, 1990; Wimmer et al., 1993), and empty spiracles (Dalton et 
al., 1989), with low affinity of the sites are activated only at higher concentrations 
and expressed in smaller anterior domains (reviewed by Ma et al., 1996). Therefore, 
a gradient of bcd protein is transformed into discrete domains of expression of 
zygotic target genes, leading to the formation of various distinctive regions of the 
embryo (Driever and Nusslein-Volhard, 1989a, 1989b; Struhl et al., 1989). 
Recent evidence has suggested that hb is not only responsible for defining 
the anterior structures but also plays the role as a morphogen for the determination 
of the polarity of the embryo. This hunchback gene is expressed both maternally 
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and zygotically. The proper spatial expression of the zygotic hb and all known bcd 
target genes requires synergistic activation by both maternal hb and bcd (Simpson-
Brose et al., 1994). The expression o fhb is necessary for specifying the correct long 
range polarity of the embryo. The maternal hb has a dose-dependent effect on the 
spatial expression of the gap genes Kriippel, knirps, and giant (Hulskamp et al., 
1990; Struhl et al., 1992). Therefore, the anterior pattern of the embryo is not 
simply determined by a single morphogen gradient but rather a combination of 
multiple morphogens. 
1.7 The anterior localization of bcd mRNA 
The gradient of bcd protein concentration is transformed into spatial 
expression of downstream development genes along the anteroposterior axis. 
However, bcd mRNA must have been first localized to the anterior pole before this 
gradient is produced. Then how does this maternal mRNA get localized to its 
destination? The mechanism of this process has not been completely understood. 
The localization of bcd mRNA begins at oogenesis and can be distinguished into 
four phases according to St. Johnston et al, 1989 (Figure 1.10). The bcd mRNA 
begins to concentrate at the oocyte at stage 5 (stages according to King, 1970; 
Mahowald and Kambysellis, 1980; Spradling 1993). Through stage 6 to 9 of 
oogenesis (the first phase), bcd mRNA accumulates in a ring at the anterior end of 
the oocyte. In stages 9 to 10a follicles (phase 2)，bcd mRNA localizes at both the 
anterior end of the oocyte and apical regions of the nurse cells. In stages 10b to 11 
(the third phase), all bcd mRNA localizes to the anterior cortex while it localizes to 
a slightly dorsal spherical region at the anterior pole between stage 12 and egg 
deposition (phase 4). 
1.8 Components required for the localization of bcd mRNA 
1.8.1 cw-acting elements 
This localization process of bcd mRNA was found to be dependent on 
several elements. One of the elements is a c/_s-acting sequence which is responsible 
for the localization. A discrete portion within the 3，untranslated region of the bcd 
mRNA is necessary for its anterior localization (Macdonald and Struhl 1988). This 
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Figure 1.10 Four phases of localization of bcd mRNA. 
The four phases of localization can be disrupted in several matemal mutants, 
exu, sww, and stau, and thus the three genes are involved in localization of 
bcd mRNA in a stepwise manner. (Adapted from St Johnston et al., 1989) 
18 
region is composed of 625 nucleotide at the 3' untranslated region (UTR) that is 
required for the localization and is sufficient to confer localization of a heterologous 
transcript to the anterior pole. It was also suggested that this sequence might form 
extended secondary structure which presented binding sites for its localization. 
Analysis o f the 3' UTR of seven Drosophila species showed certain degree of 
homology (Macdonald, 1990). The primary sequences of the six species were up to 
50 % divergent from the D. melanogaster gene, but they showed patchy homology 
throughout most of the region. Furthermore, all sequences of the seven species can 
potentially form a large stereotypic secondary structure (Figure 1.11), indicating 
that they were highly conserved in secondary structures despite divergence of the 
primary sequences. Besides, the 3’ UTR showed functional conservation. The 3， 
UTR from three evolutionarily distinct species were tested interspecifically for bcd 
mRNA localization in D. melanogaster and each of them was found to be 
functionally interchangeable (Macdonald, 1990). Thus these 3，UTR are both 
structurally and functionally conserved and are essential for bcd mRNA localization. 
1.8.1.1 BLE1 at 3，UTR directs localization ofbcd mRNA 
I , 
I Further investigation on a series of bcd transgenes carrying small deletions 
i 
I 
in the 3' untranslated region had revealed that a bcd localization element 1 (BLE1) 
was responsible for early steps of localization (Macdonald et al., 1993). The BLE1 
contained a sequence of 50 nucleotides and a transgenic mutant lacking this 
sequence had lost all the early localization. In addition, some other deletions within 
the 3’ untranslated region were found to impair localization, suggesting that more 
than one localization elements would be present. Each of these elements may act on 
different steps of the localization process. One comparable example is the multiple 
localization elements in the 3' untranslated region of the oskar mRNA, with 
different elements mediating different steps in its localization to the posterior pole 
of the oocyte (Kim-Ha et al., 1993, reviewed by Macdonald et al., 1993). 
Recent finding showed that another element, exl protein was involved in bcd 
mRNA localization process. It was demonstrated that there was a correlation 
between in vitro exl binding and one phase of in vivo localization directed by BLE1, 
implicating exl in that localization event (Macdonald et al., 1995). 
19 
’'，： 、％ 
\ 、 》 „ 
, \ X j ^ % / 7 . 
c ^ , v % . . . # 
V^% \ % , � # 7 
^ P X ^ ^ f 
\^务、、 \ 方 / 
| |K ^ . 4- Z x V t ^ y ^ V v y : � , / \ : v - “ � �/ 
、 ‘ 》 • • i - S >1J »i ' / 
5-? / 
*-W 、二？ 
A " ' * » 為"• 'A 
A c:j ^ J:1 II 
I 
,.'‘：•：'”’ variable / 、 
I 、路。 
随 I \ : ¾ 
'r \ % 广、 , c.oc;^^ .C-<J#^C^ V«- . ' nt - S- <. • 15 >»ly * \ ^ ^x'<-^ 务 * >/',. <； 
\ NV^c^ . , # 
a N ^ j r / 
r%. v % . # < ^ / 
\ % , \ V，： Z 
\^%Q ^ # V ^ 
丨 K S 4 ^ 
: \ � � , 7 
\ 广* "”\ / 
\ r .. c -i • A k V / 
\ … 。 ” : ” 、 . ^ / 
C-4 s ,*•“ 'e:j 
V - A 
;:•* 
i :u • • 
„ o ” 
B , ,� J� 
M " r 




:ea: ->c i<40*"c* • VAX - '< •!-• - c • 5 • t s :^ l r * 
Figure 1.11 The conservation of the stereotypic secondary structure of 
the 3，untranslated regions O^TR) of bcd mRNA from two Drosophila 
species. 
A. Predicted structure of D. melanogaster. B. Predicted structure of D. virilis. 
The 3 ‘ UTR of the two species are predicted to form conserved secondary 
structures with five major stems and a variable region. (Adapted from 
Macdonald, 1990) 
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A simple model of localization of bcd mRNA was proposed that once hcd 
mRNA is transcribed in the nurse celis, it is recognized and trapped after passing 
from the nurse cells to the anterior end of the developing oocyte through 
cytoplasmic bridges (Macdonald and Struhl 1988). In this model, certain receptors 
anchoring on structural components of the oocyte must be present to recognize and 
bind the bcd mRNA. These receptors do not need to be localized since the polarized 
entry of bcd mRNA already allows the anterior localization. Nevertheless, this 
model does not agree with other observation on relocalization o f bcd mRNA after 
the treatment with microtubule destabilizing drugs (Pokrywka and Stephenson, 
1991). Eggs treated with nocodazole，a microtubule destabilizing drug, had their 
bcd mRNA released from the anterior cortex and dispersed into the oocyte 
cytoplasm. After rinsing to remove the drug, most o f bcd mRNA was relocalized at 
the anterior cortex. Although some bcd mRNA was mislocalized along the cortex at 
more posterior positions, higher concentrations of bcd mRNA were always present 
at the anterior tip. This observation indicated that the drug-released bcd mRNA 
could be relocalized to the anterior end after removal of the drug. Therefore, the 
localization of bcd mRNA is unlikely to involve simple transporting and trapping 
mechanisms. The localization of bcd mRNA must depend on other mechanisms and 
may require additional components. 
1.8.2 7>flW5-acting elements 
1.8.2.1 exuperantia, swallow and staufen are necessary for localization of bcd 
mRNA 
There are several trans-diCimg elements responsible for bcd mRNA 
localization. Three anterior maternal genes, exuperantia (exu), swallow (sww) and 
staufen {stau) (Gans etal” 1975; Schupbach and Weischaus, 1986) are involved in 
the localization process (Frohnh6fer and Nusslein-Volhard, 1987; Stephenson et al.) 
1988; St. Johnston et a/.，1989). Mutations of these three genes resulted in the loss 
of anterior structures (Figure 1.12). Defects in localization of bcd mRNA were 
observed in all of these mutants (Figure 1.13). According to St. Johnston et al. 
(1989), exu mutants display the earliest defects in the localization among the three 
mutations. The initial localization of bcd mRNA during stages 5 to 7 is normal 
relative to the wild type. From stages 8 to 9, bcd mRNA is localized at the anterior 
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Figure 1.12 Cuticle patterns of maternal gene mutants showing loss 
of the anterior pattern in larvae. 
A. w i ld type. B. bcd[i, a strong bcd allele. Head and thoracic structures 
are replaced by a duplicated telson and the anterior abdomen is 
defective. C. exu mutant, and D. sww mutant shows loss o f head 
structures. E. stau mutant displays anterior as well as abdominal defects. 
(Adapted from Driever and Niisslein-Volhard, 1988b) 
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Figure 1.13 Defects in localization of bcd m R N A of the maternal gene 
mutations. 
In the three mutants, exu, sww and stau, bcd mRNA is not tightly localized 
to the anterior pole o f the oocyte. The exu mutants display the earliest 
defects in the localization and result in loss o f the anterior localization in the 
oocyte and the apical localization in the nurse cells. (Adapted from 
Lawrence, 1992) 
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cortex of the oocyte but the mRNAs are more diffused as opposed to the tight 
localization as seen in the wild type. Furthermore, bcd mRNA is localized neither at 
the anterior pole of the stage 10 oocyte nor to the apical regions of the nurse cells 
in the mutants. Instead, it shows a uniform distribution within the oocyte and nurse 
cells. 
In sww ovaries, the localization of bcd mRNA is entirely normal up to stage 
lOa. During stages 10b and 11, the anterior localization of bcd RNA appears to slip 
posteriorly and become more diffiised. By stage 12, all bcd mRNA is released from 
the cortex and form a shallow anterior to posterior gradient. In stau mutants, bcd 
mRNA seems to have normal localization up until stage 12 and it is released from 
the anterior pole after this stage. The localization o f bcd mRNA forms a gradient in 
the early embryos. Al l the mutations cause a loss or shallower gradient of bcd 
protein and account for the loss of the anterior body structures in the embryos. 
1.8.2.2 exu protein is an absolute requirement for the localization 
The three maternal genes are required in the localization of bcd mRNA in a 
stepwise manner (Figure 1.10) (St Johnston et al.，1989). As exu mutations produce 
an early defect in the localization, it seems to play an important role for localization 
of bcd mRNA during oogenesis. The exu gene seemed to be not necessary for the 
maintenance of the localization during late stages of oogenesis and early 
embryogenesis but rather for the establishment o f the localization in the developing 
oocyte (Macdonald et al., 1991; Marcey et al., 1991). Other than in oogenesis, exu 
was found to also function in spermatogenesis (Hazelrigg et al., 1990) and several 
exu alleles were analyzed to be male sterile. The exu gene encodes overlapping sex-
specific transcripts during oogenesis and spermatogenesis. Three kinds of mRNA 
are transcribed from exu gene. One is a major female germline-specific 2.1 kb 
transcript and the second one is a male germline-specific 2.9 kb transcript which 
overlaps with the female one, while the third one is rare 2.5 kb transcript which is 
expressed in somatic cells (Marcey et al., 1991). Three exons in exu mRNA 
comprise an open reading frame (ORP) of 1596 nucleotides. Translation of the exu 
ORF yields a protein of 532 amino acids with a predicted molecular weight of 
57981 Daltons. The exu protein has a predicted pI of 10.12 and contains several 
basic, arginine-rich stretches (Marcey et al., 1991). 
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1.8.2.3 Potential functions of exu based on the coding sequence 
Database search showed that exu protein has no significant homology to any 
known proteins (Macdonald et al., 1991; Marcey et al., 1991). However, by 
searching for common functional motifs, a PEST domain, which is thought to 
confer susceptibility to rapid proteolysis, was located at residues 435-450 (Marcey 
et al., 1991). Besides, the analysis of a mutant exu^^^^ revealed that a basic residue, 
arginine339 〇『 x^u protein is important for exu function in females. Furthermore, 
there are no previously defined RNA recognition motifs (Bandziulis et al., 1989; 
Query et al., 1989) found in the sequence of exu protein but the presence of certain 
ribonucleoprotein (RNP)-like motifs (Marcey et al., 1991) may reflect potential 
interactions of exu protein to nucleic acids. In fact, colocalization of bcd mRNA 
and exu protein was observed at some stages during oogenesis (Macdonald et al., 
1991). As the colocalization occurred only at early stages (stages 5-lOb) but not in 
late stages (after stage 10b and embryo), the interaction between bcd mRNA and 
exu protein must be transient and indirect. No exu protein is detectable in the 
embryo, where bcd mRNA is tightly localized at the anterior cortex, indicating that 
exu protein acts in the initial steps of localization but does not play for a persistent 
role (Macdonald et al., 1991). I f exu protein does bind bcd mRNA in its role in bcd 
mRNA localization, exu should have certain recognition motifs for its binding. 
However, the recognition may be very specific for bcd mRNA binding and so it is 
possible that exu contains a previously unknown sequence for RNA binding. 
Alternatively, exu may not directly interact with bcd mRNA but may link to bcd 
mRNA by intermediate components. 
The absence of exu protein in late oocytes (stages 10 onwards) and the 
embryo indicates that exu must function in the early oogenesis (Marcey et al” 
1991). As the localization of bcd mRNA persists through the stages where no exu 
protein presents, exu protein is unlikely to serve as a molecular bridge between bcd 
mRNA and the structural components of the oocyte. Instead, exu protein may either 
activate a component of the oocyte to bind bcd mRNA, or may act as a transient 
docking protein which connects bcd mRNA to its binding targets or may modify 
bcd mRNA to allow subsequent binding (Marcey et al, 1991). 
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1.8.2.4 Microtubules dependence of the localization 
Another trans-acting element necessary for bcd mRNA localization is a 
cytoskeletal component, microtubules. Several biological processes involving 
cytoskeletal elements in other systems have been already investigated. In 
Caenorhabditis elegans, P-granules are segregated into the posterior cell at the first 
cleavage by a mechanism that requires microfilament function (Strome and Wood, 
1983; Hi l l and Strome, 1988), while in Xenopus oocytes, both microtubules and 
microfilaments are required for the localization o f Vgl R N A to the vegetal cortex 
(Yisraeli et aL, 1990). 
Cytoskeletal components have long been known to play a role in localization 
o f developmental determinants. It has been shown that microtubules are absolutely 
required for localization of bcd mRNA. Drugs that depolymerize microtubules 
perturbed all aspects of bcd mRNA localization, suggesting that the cortical 
cytoskeleton is an important element for the mechanism of localization (Pokxywka 
and Stephenson, 1991). The study using destabilizing drugs, nocodazole, colchicine 
and tubulozole-C revealed that all stages of anterior localization o f bcd mRNA in 
the oocytes (Pokrywka and Stephenson, 1991; Kwan and Luk, unpublished; also 
see section 3.2) as well as the characteristic apical localization at nurse cells were 
lost. The observation suggested that microtubules are necessary for both the initial 
localization of bcd mRNA and the maintenance of its localization. Further study 
showed that the egg chambers recovered from drug treatment had their bcd mRNA, 
at least mostly, relocalized to the anterior margin (Pokrywka and Stephenson, 
1991), suggesting that bcd mRNA is localized only in the presence of microtubules. 
However, excessive microtubules polymerization also altered bcd mRNA 
localization. Treatment with taxol resulted in ectopic localization in which bcd 
mRNA was dispersed within the oocyte and concentrated in aggregates at the 
lateral cortex as well as around the oocyte nucleus (Pokrywka and Stephenson, 
1991). Therefore, microtubules are involved either directly in localizing bcd mRNA 
or indirectly in maintaining the integrity of other cytoskeletal functions required for 
the localization. 
Pokrywka and Stephenson (1994) provided further evidence that both bcd 
mRNA and exu protein were associated with microtubules. By cellular 
fractionation, both bcd mRNA and exu protein were found to be associated with a 
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detergent-insoluble fraction and their associations could be released by microtubule-
destabilizing drugs. This revealed that both bcd mRNA and exu protein were 
associated with components, presumably microtubules in the detergent-insoluble 
fraction. However, evidence which showed a direct association of exu protein and 
microtubules is lacking. 
1.8.2.5 Microtubule polarity directs localization of bcd mRNA 
Cell biological study provided forther insight into the mechanism of 
localization of RNA of maternal genes by microtubules organization. The 
distribution of microtubules during oogenesis provided a simplified model on how 
microtubules direct RNA localization. As discussed in section 1.1, the 
reorganization of microtubule distribution is essential for localization of bcd and osk 
mRNAs. In the PKA mutants, the microtubule distribution is as normal as the wild 
type in the early egg chambers (stages 1-6), but the MTOC persists at the posterior 
end, in addition to the microtubule nucleating region at the anterior end of the 
oocyte in stages 7 and 8 egg chambers (Figure 1.14). At the same stages, ectopic 
localization of RNAs, in which a transient accumulation of bcd mRNA at the 
posterior in addition to the normal anterior localization, and the concentration of 
osk mRNA in the middle instead of localiztion to the posterior of the oocyte, was 
observed (Figure 1.14). The polarity of the microtubules and the localization of the 
RNAs suggest that the localization of bcd mRNA is associated with minus-end-
directed motors, while the transportation of osk mRNA is associated with plus-end-
directed motors. Thus a uniform polarized framework of microtubules is necessary 
for directing the asymmetrical distribution of the RNAs. 
1.9 Functions of exu in localization of bcd mRNA 
Although many components have been identified, the mechanism on how 
they work together to allow localization of bcd mRNA is still unknown. At least 
two components, exu protein and microtubules, are known to play an important 
role in the localization process. Nonetheless, the study of the functional domains of 
exu protein as well as its interaction with components such as microtubules will 
provide further insight into the localization mechanism of bcd mRNA, which 
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Figure 1.14 Polarity of microtubules and distribution of mRNAs 
in PKA mutants. 
In PKA mutants, microtubule nucleating regions, which correspond to 
the minor ends of microtubules, were found at both anterior and 
posterior poles, creating an abnormal polarity of microtubules in the 
stage 7-8 oocyte. The bcd mRNA was localized at both poles of the 
oocyte, suggesting its transportation by minus-end directed motors, 
while osk mRNA was concentrated in middle of the oocyte, suggesting its association with plus-end directed motors. I 28 j 




Characterization of deletion mutants of exu 
2.1 Introduction 
The exu gene is absolutely required for the correct localization of bcd 
mRNA (Frohnhofer and Nusslein-Volhard, 1987; Stephenson et al., 1988; St 
Johnston et al. 1989). The exu protein colocalizes with bcd mRNA at mid-
oogenesis (Macdonald et al., 1991) and it is likely to have domains that interact, 
either directly or indirectly, with bcd mRNA. Exploration and characterization of 
the functional domains wil l provide invaluable information on how a protein directs 
the localization of a polynucleotide which in turn determines the polarity of a 
developing egg. 
Although the exu gene has been already cloned, the predicted protein 
sequence has neither homology to any characterized gene nor known common 
functional motifs (Marcey et al., 1991; Macdonald et al. 1991). Thus the protein 
does not provide any clue for its function. To locate the unknown functional 
domains of such a protein, the entire protein sequence would need to be examined 
and potentially important regions can be identified by molecular genetic analysis. By 
deletion analysis, potential functional domains of many different kinds of proteins, 
such as human interleukin-6 (EL-6) (Brakenhnoff et al., 1989), rat beta 1 thyroid 
hormone receptor (0'Donnell and Koenig, 1990), and bovine ras p21 GTPase 
activating protein (GAP) (Marshall et al., 1989) have been located and analyzed. In 
the case of exu, a series of deletion constructs which spanned almost the entire 
coding sequence were introduced into the germline by P-element transformation. 
Failure of these deletion mutants to complement the exu null allele would reflect the 
loss of stmcturaL^ functional regions and would facilitate the identification of 
potentially functional domains. Subsequent analysis of the functional domains would 
help us understand the function of exu and ultimately the localization of the anterior 
morphogen bicoid. 
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2.2 Construction of deletion mutants of exu 
2.2.1 Materials and Methods 
A molecular genetic approach was adopted to locate and determine which 
portion(s) of the exu protein is critical for its function. By taking advantage of the 
available restriction sites within the coding sequence, deletions were introduced into 
exu gene and resulted in eight different mutant constructs (Figure 2.1) (Kwan and 
Luk, manuscript in preparation). The constructs with deletions at the C-terminus 
(mutants A426-531 and A390-531) were tailed with a polylinker that contained 
termination codons in all three reading frames that allowed premature termination 
oftranslation. The exu proteins encoded by these constructs were thus truncated at 
the C-terminus. Other constructs were produced by restriction enzyme digestion 
and re-ligation either with (mutants A 54-193, A 194-375 and A 390-440) or 
without (mutants A 302-375, A 374-388 and A 442-503) linkers to restore the 
reading frame. All constructs were sequence-confirmed by dideoxy DNA 
sequencing. 
The mutant constructs were introduced into the germline of w " " flies by P-
element mediated transformation (Rubin and Spradling, 1982). Transformants were 
identified by eye color, and balanced stocks were established for each independent 
lines of each mutation construct (Kwan and Luk, unpublished). 
The transgenic constructs were tested for their ability to rescue the exit。 
maternal-effect lethality according to the method described by Macdonald et al. 
(1991). The exu^ allele has a nonsense mutation at amino residue 53 of the 
predicted protein sequence (Macdonald et al., 1991). The mutation causes the 
premature termination of translation and is thus an exu protein null mutation. Eggs 
laid by females flies in homozygous exu'^ background are nonviable and cannot 
emerge as viable adults. The transgenic constructs were placed in the exu^ 
background by appropriate crosses. Virgin females of the genotype exu'^ / exu'。； 
transgene construct / TM2 were crossed to wild type males to test for rescue of 
maternal-effect lethality. I f adult progeny was emerged, the rescue test would be 
scored as positive; otherwise it would be scored as negative. 
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i 
1 100 200 300 400 500 a. a. 
complete i 1 ' ' 1 
exu protein 
A54-193 I I I I 
A194-375 I I I 
A302-375 I I I 
A374-388 i I I 丨 
A390-440 I I I I 
A442-503 I I • 
A426-531 I 
A390-531 I “ 
Fig. 2.1 Deletion mutants of exu, Restriction sites present in the exu sequence 
were used to remove unwanted fragments and the remaining fragments were re-
ligated. Linkers were added before ligation to restore the reading frame in some 
deletion mutants and translation termination codons were introduced in those 
mutants with C-terminus being deleted. All the deletion mutants were sequence-
confirmed the in-frame mutations. Open bars represent the exu protein sequence. 
Empty spaces between bars represent the various deletions. The two C-terminal 
deletion mutants (A 426-531, A 390-531) are represented by two truncated bars. 
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2.2.2 Results 
At least two independent transgenic lines from each construct were tested 
for rescue. Of the eight transgenic constructs, one was found to be able to rescue 
the maternal-effect lethality, indicating that the mutant transgene, mutant A442-503 
retained the full activity of the wild type exu gene. This deletion mutant, although 
having 62 internal amino acid residues deleted at the C-terminus, can replace the 
wild type exu gene to allow viable eggs to be produced. Thus this mutant was 
functionally indistinguishable from the wild type. None of the other seven transgenic 
constructs produced viable larvae indicating that they cannot replace the wild type 
exu gene (Table 2.1). However, mutant A 426-531 always produced one or two 
adult flies from a large number of eggs laid. Although viable progeny was observed, 
this line was considered as non-rescue as most of the eggs were not viable. By 
comparison of sequences between the rescue mutant A442-503 and the non-rescue 
mutant A426-531, the only difference was that the latter mutant had additional 16 
amino acid residues deleted. These residues may play an important role in exu 
functions. 
As mutant A442-503 still retained the full activity of the wild type exu gene, 
the deleted region within this mutant was dispensable for function. This region 
comprises 11.6 % of the whole exu protein and overlaps with part of the PEST 
domain located from residues 435 to 450. The PEST domain has been found in 
certain short-lived proteins and has been postulated to confer rapid proteolysis 
(Rogers et a/., 1986; Rechsteiner et al, 1987). In mutant A442-503, only part of 
the PEST domain was deleted but the whole domain was removed in the non-rescue 
mutant A426-531. Therefore, it is possible that the removal of the whole PEST 
domain would account for the failure of rescue in mutant A426-531. Nonetheless, 
relationship between the presence of the PEST domain and the function of exu 
protein is at present unclear. 
33 
Table 2.1 Test for rescue of the maternal-effect lethality of the deletion 
mutants 










2.3 Analysis of exu protein in deletion mutants 
The mutant constructs were tested i f they expressed exu proteins in vivo 
during oogenesis. Total proteins from ovaries isolated from female flies 
homozygous for exu were analyzed by immunoblot. 
2.3.1 Materials and Methods 
2.3.1.1 Preparation of total ovary protein from the transgenic flies 
Ovaries isolated from two-day-old female flies homozygous for exu'^ and 
contained at least one copy of the various transgenes were homogenized in 2X SDS 
sample buffer (SB) (2X: 62.5 m M Tris-HCl, pH 6.8，2 % SDS, 5 % p-
mercaptoethanol, 10 % glycerol, 0.005 % bromophenol blue) in a ratio of one pair 
of ovary to 10 ^il o f SB. Content of the ovary extracts was separated by SDS-
PAGE and the presence of exu protein was detected by western blot analysis using 
an anti-exu antibody. The anti-exu antibody was a polyclonal antibody that allowed 
different epitopes to be recognized and thus even the deleted mutant exu proteins 
would be efficiently detected. 
2.3.1.2Analysis of protein content by SDS PolyacryIamide Gel Electrophoresis 
(PAGE) and immunoblotting 
The proteins were separated by SDS PAGE and then transferred onto 
nitrocellulose paper. The exu protein was probed with a rabbit anti-exu antibody 
and then a secondary antibody of alkaline phosphatase-conjugated anti-rabbit 
antibody. The color reaction was developed with NBT and BCEP. Details of the 
procedures of SDS PAGE and immunoblotting can be found in Appendix A. 
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2.3.2 Results 
A western blot analysis of exu protein of ovary extracts of the transgenic 
flies is shown in Fig. 2.2. Ovary extracts from homozygous exu'' were used as a 
negative control in which no exu protein was detected while ovary extracts from the 
w"76, served as a positive control. The wild type exu appeared as multiple bands due 
to post-translational modification at multiple sites by phosphorylation (Cheung et 
al., manuscript in preparation). Among the eight deletion transgenic constructs, exu 
protein bands were detected in six of them. Al l the bands were shown to have 
reductions in molecular weight corresponding to their respective deletions (Table 
2.2). Only the rescue mutant, mutant A 442-503, consisted of an apparent doublet 
of exu protein while others appeared as single bands. This reflected that certain 
phosphorylation sites might have been retained in this mutant for postranslational 
modifications. Two transgenic constructs (mutants A 194-375 and A 390-531) had 
no detectable exu protein. One possible explanation for the lack of exu protein was 
the large deletions in these two constructs which rendered them unstable. Besides, it 
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Figure 2.2 Analysis of exu protein in ovary extract of the deletion 
mutants. 
The exu protein was detected by anti-exu antibody. Multiple isoforms of exu protein with 
different molecular weights can be detected in the wild type ovary extract. As a negative 
control, the ovary extract of the exu^ protein null mutant was run in parallel with that of 
the wild type. 
Lane: exu® ,^ ovary extracts of the protein null mutant; wild type, ovary extracts of the wild 
type; A xxx-xxx, ovary extracts of the deletion mutants. 
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Table 2.2 The theoretical molecular weight and apparent relative molecular 
weight determined by SDS PAGE of exu proteins of the deletion 
mutants 
Deletion mutants theoretical Mr apparent Mr 
A54-193 43,000 41,500 
A194-375 38,000 exu undetectable 
A302-375 49,000 50,600 
A374-388 56,000 55,500 
A390-440 52,000 53,400 
A442-503 51,000 50,000 
A426-531 46,000 42,100 
A390-531 42,000 exu undetectable 
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2.4 Localization of bcd mRNA and exu protein in oogenesis 
2.4.1 Introduction 
The spatial and temporal distribution o f bcd mRNA is important for its 
localization to the anterior cortex o f the oocyte. Four stages of bcd mRNA 
localization have been described by St. Johnston et al. (1989) and mutations of exu, 
sww and stau disrupt these stages of localization in a stepwise manner. Therefore, 
the localization seems to be proceeded in multiple steps in which bcd mRNA has to 
be localized correctly in each stage of oogenesis to achieve a tight localization in the 
embryo. 
The colocalization of bcd mRNA and exu protein strongly suggests that 
they are associated during some stages of oogenesis. As their associations are only 
transient, exu protein would not involve in anchoring bcd mRNA by direct binding 
at the anterior pole of the oocyte. Rather, exu protein acts in initial steps of 
localization but not in maintenance of localization at late oogenesis and the embryo 
(Macdonald et al., 1991; Marcey et al., 1991). 
Localization of several RNAs has been already known to depend on the 
preceding localization of other components. The posterior localization of nanos, 
cyclin B, and gcl mRNAs requires prior localization of oskar mRNA and oskar, 
staufen, and vasa proteins (RafF, et al., 1990, Jongens et al., 1992, Wang, et al., 
1994; reviewed by St. Johnston, 1995). The preceding components may involve in 
binding to, or preparing binding sites for, the components which arrive later in 
oogenesis. 
The spatial and temporal distribution of exu protein may be critical for 
localization of bcd mRNA. Localization of exu protein precedes that of bcd mRNA 
in the oocyte, and exu appears to concentrate in the oocyte at very early stages 
(Macdonald et al.，1991). Exu protein would thus have begun to function much 
earlier before bcd mRNA arrive at the oocyte. The function of the prior localization 
of exu would therefore be not directly involved in the binding of bcd mRNA but 
rather in preparing the localization machinery for bcd mRNA. Subsequent 
colocalization of exu protein and bcd mRNA at mid-oogenesis may then involve 
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either a direct or an indirect association of the two components which confers the 
tight anterior localization of bcd mRNA at late oogenesis. Thus, the localization of 
exu protein may play an essential role in the successful localization of bcd mRNA. 
• 
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2.4.2 Spatial and temporal distribution of exu protein in the deletion 
mutants 
To determine the significance of different regions of exu coding sequence on 
the spatial and temporal localization o f exu protein, egg chambers were isolated 
from the deletion mutants and were analyzed by immunohistochemical staining 
using an anti-exu antibody. 
2.4.2.1 Materials and Methods 
The immunohistochemical staining protocol was essentially as described by 
Macdonald et al. (1991) wi th modifications. About 20 pairs of ovaries were 
dissected from well-fed two-day-old female flies in PBS (8g NaCl, 0.2 g KC1, 1.44 
g Na2HPO4, and 0.24 g KH2PO4 in 1 L ofdouble-distilled water, adjusted to pH 7.4 
with HC1). The ovaries were briefly washed in PBS in a microfuge tube. Individual 
ovarioles were dispersed by repeatedly pipeting the ovaries in a 50 ^il volume of 
PBS. 
To allow better penetration by antibodies, egg chambers were incubated in 
0.375M KC1 at 37。C for 30 minutes. The egg chambers were washed twice in PBS 
and then fixed in 4% formaldehyde in PEM buffer (0.1 M Pf fES, pH 6.8, 2 m M 
MgSO4, 1 m M EGTA) for 17 minutes at room temperature with rotation. The egg 
chambers were briefly washed twice in PTW (PBS, 0.1 % Tween 20)，twice for 30 
minutes in PTW, and then incubated with a rabbit anti-exu antibody diluted 1:800 in 
TNBTT (50 m M Tris-Cl pH 7.5, 150 m M NaCl, 0.1 % BSA, 0.1 % Triton X-100, 
0.05 % thimerosal). Aiter incubation overnight at 4°C with rotation, the egg 
chambers were washed twice in TNBTT and then blocked with 2% normal goat 
serum (Antibodies Incorporated) in TNBTT for 30 minutes at room temperature. 
After washing twice for 30 minutes in TNBTT, the egg chambers were further 
incubated with an FITC-conjugated goat anti-rabbit secondary antibody (Vector 
Laboratories) in 1:1200 dilution in TNBTT containing 1 % BSA for two hours at 
room temperature. The egg chambers were washed three times for 15 minutes in 
PTW and then mounted in fluorescent label mounting medium (0.1 M Tris-HCl, pH 
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8.0, 90 % glycerol, 2.3 % of l,4-diazobicyclo-(2,2,2)-octane (DABCO) (w/v), 0.02 
% sodium azide), and examined with a Zeiss epifluorescent microscope. 
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2.4.2.2 Results 
Distribution of exu in wild type ovaries 
The spatial and temporal distribution of exu protein was essentially as those 
described previously (Marcey et al., 1991; Macdonald et al., 1991; Wang and 
Hazerigg, 1994). In the wild type ovaries, exu protein was expressed in the 
germarium as well as in the oocytes of early stages egg chambers (Figure 2.3A). 
The exu protein was observed to be localized exclusively in the oocytes from stage 
3 to stage 8 (stages according to King, 1970; Mahowald and Kambysellis, 1980; 
Spradling, 1993). Beginning from stage 8, exu protein was localized in the nurse 
cells but most of the exu still remained in the oocyte. At stage 9, exu protein 
continued to accumulate in the apical regions of the nurse cells and there was a 
concomitant reduction of exu protein in the oocyte, where little or no exu protein 
accumulated in stage 1 OA. 
Distribution of exu in exu'^ mutant 
As the exifc allele is a protein null mutation, essentially background staining 
was observed at all stages of egg chambers as expected (Figure 2.3A). The egg 
chambers exhibited a homogenous faint background staining indicating no 
detectable exu protein. 
Distribution of exu in deletion mutants 
Several groups of pattern of the spatial and temporal distribution of exu 
protein were observed in the deletion mutants. One of the deletion mutants 
exhibited very similar distribution of exu protein as that of the wild type. This 
mutant, A 442-503 had exu protein localized in early oocytes and in the nurse cells 
at late stages (Figure 2.3A). It was noteworthy that this mutant carried a transgene 
that could rescue the maternal-effect lethality and had the same distribution pattern 
of exu protein as the wild type. Thus, this transgene was functionally 
indistinguishable from that of the wild type exu although it had 62 internal amino 
acid residues deleted (see section 2.2.2). 
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The second group had distribution pattern resembling only some of the 
localization pattern of the wild type. In two of the mutants, A302-375 and A374-
388 (Figure 2.3B), their distribution of exu protein differed from the wild type only 
in the loss of localization at the early stages oocytes (from germarium up to stage 
5), where little or no exu protein was detected. The absence of localization would 
either be due to the failure of exu to be localized or to the lack of expression in the 
early stages. Although localization was observed in the oocytes of the stages 6 to 9 
egg chambers, the level of exu protein was much lower than that of the wild type. In 
addition, exu protein was concentrated in stage 1 OA nurse cells and localized at the 
apical regions as in the wild type. 
The third group had one part of the distribution pattern similar to that of the 
second group in which no localization of exu was observed from germarium to 
stage 5 and low level of localization was observed in oocytes between stages 6 to 9 
egg chambers. However, in mutants A390-440 and A426-531 (Figure 2.3C), the 
level of exu protein concentrated in the nurse cells was much lower than that of the 
second group in stage 10A egg chambers. Western blot analysis had confirmed that 
the level of exu protein in these two mutants was lower than that of the mutants of 
the second group. Therefore, the absence of concentration of exu in stage 10A 
nurse cells of mutants A390-440 and A426-531 might be due to the low level of 
expression, and thus the mutants from both the second and the third groups were 
represented similar distribution pattern of exu at early stages. None of these 
transgenes was able to rescue the maternal-effect lethality and hence the distribution 
patterns of the mutated exu protein appeared to correlate with their loss of function. 
In the fourth group of distribution pattern, mutant A54-193 (Figure 2.3D) 
had no localization of exu protein at very early egg chambers up to stage 9. As exu 
protein bands were detected by western blot analysis, the absence of localization 
was due to the inability of the exu protein to get localized which resulted in a 
homogenous distribution of the protein. Alternatively, the expression of exu was 
lower in the early stages but began to accumulate in stage 10A egg chambers, 
where low level of exu protein was detected in the nurse cells. 
In the fifth kind of distribution pattern, egg chambers of mutants A194-375 
and A390-531 (Figure 2.3E), had no detectable exu protein. The phenotype of these 
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two mutants was essentially the same as that of the protein null mutant exu'\ This 
observation was confirmed by western blot analysis in which little or no exu protein 
was detected. Therefore the absence of exu localization was due to lack of exu 







































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































2.4.3 Spatial and temporal distribution of bcd mRNA in the deletion mutants 
A function assay of the exu deletion mutants was performed by whole 
mount in situ hybridization to analyze the spatial and temporal distribution of bcd 
mRNA. Failure of proper localization of bcd mRNA represented loss o f function of 
the exu and thus the functional significance of the deleted coding sequences could 
be examined. 
2.4.3.1 Materials and Methods 
2.4.3.1.1 Principles ofDIG^-labeling and in situ hybridization 
The labeling reaction was performed using the D I G D N A labeling and 
detection kit (Boehringer) with modifications as described by Macdonald et al. 
(1991). D N A was labeled by random primed incorporation of digoxigenin (DIG)-
labeled deoxyuridine-triphosphate (dUTP). A steroid hapten digoxigenin was linked 
to the dUTP through a spacer arm. This D IG hapten allowed easy recognition of 
the target hybrids after hybridization. 
The template double-stranded D N A was first linearized and then denatured 
by heating. Random hexanucleotides that bind to the single-stranded D N A were 
used as primers for DNA replication in the presence of dNTP and DIG-conjugated 
dUTP (Figure 2.4A). The egg chambers were fixed and washed, and then probed 
with the DIG-labeled DNA as described in section 2.4.3.1.3 (Figure 2.4B). After 
hybridization, the hybrids were detected by enzyme-linked immunoassay using anti-
DIG-alkaline phosphatase conjugate and subsequent enzyme-catalyzed colour 
reaction with 5-bromo-4-chloro-3-indolyl phosphate (X-phosphate) and nitro blue 
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Figure 2.4A Synthesis of DIG labeled DNA probe by random priming. 
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2.4.3.1.2 Synthesis ofDIG-labeIed hcd DNA probe 
A 1.7 kb EcoRJ / RV fragment was released from a plasmid p l 122, which 
contained the bcd cDNA clone, for synthesis of DIG-labeled probe. Details of the 
procedures for preparation o f D N A template can be found in Appendix A. 
DIG-labeled D N A probe was made by random primed labeling on the DNA 
template using a Boehringer Mannheim genius kit (DIG D N A Labeling and 
Detection Kit, Non-radioactive). The purified RI / RV fragment was resuspended in 
58 ^il double distilled water to make a final volume of 100 ^il. The tube was boiled 
for 10 minutes and then quickly chilled on a dry ice / ethanol bath. The frozen DNA 
was allowed to thaw at room temperature. Before all the D N A solution was 
thawed, the following were added in sequence. 
(1) l O X L B 10 ^il 
(LB: 50 mM HEPES, pH 6.9, 5 m M MgCb, 2 mM DTT) 
j (2) lOXhexamer 10 ^il 
(3) 10X dNTP 10 ^il 
(4) Klenow (2 U/^il) 2 ^d 
i The content was mixed and incubated overnight at 37°C. The labeled DNA was 
ethanol-precipitated and resuspended in 1 ml hybridization solution. The probe was 
kept at -20°C before use. 
The efficiency of the labeling reaction was tested by immobilizing the probe 
on nitrocellulose paper, detecting with an anti-DIG antibody and NBT / X-
phosphate color reaction. Details of probe testing can be found in Appendix A. 
2.4.3.1.3 in situ hybridization of bcd mRNA in egg chambers using DIG-
labeled DNA probe 
I The in situ hybridization was based on the protocol described by Macdonald 
(1992) with modifications. About 20 pairs of ovaries were dissected from well-fed 
two-day-old female flies in PBS. The ovaries were dispersed in the same way as in 
the immunohistochemical staining. 
The egg chambers were incubated in 0.75 M KC1 in PBS at 37°C for 30 
minutes. The KC1 solution was removed and the egg chambers were rinsed twice in 





I minutes with rotation (usually by rotating the microfoge on a motor-driven rotator) 
1 
1 
I and then were rinsed three times for 5 minutes in PTW. In order to enhance probe 
penetration, the egg chambers were digested in 50 ugArd of non-digested proteinase 
K (Boehringer) in PTW for 8 to 9 minutes. The proteinase K digestion was stopped 
by incubation in 2 mgAnl of glycine in PTW for 2 minutes. The egg chambers were 
rinsed three times for 5 minutes in PTW and then refixed in 4 % paraformaldehyde 
] in PBS for 20 minutes. 
I 
I The egg chambers were washed at least five times for 5 minutes in PTW, 
j followed by a wash in 1:1 mixture of PTW and hybridization solution (50 % 
! 
formamide, 5X SSC, 100 ug/ml sonicated salmon sperm DNA, 50 ugAnl heparin, 
I 0.1 % Tween 20) for 10 minutes and a wash in hybridization solution for 10 
:.! 
minutes. About 0.5 ml of hybridization solution was heated in a boiling water bath 
for 5 minutes and then chilled on ice. The egg chambers were prehybridized in this 
solution for one hour at 50°C and then hybridized with 100-150 ^1 of denatured 
DIG-labeled DNA probein hybridization solution overnight at 50°C 
At the end of the hybridization, the egg chambers were washed for 20 
minutes in hybridization solution at 50°C. A series of washes were done 
sequentially in the following solutions for 20 minutes at 50。C. 
(1) 4 parts ofhybridization solution and 1 part o fPTW 
(2) 3 parts ofhybridization solution and 2 parts o fPTW 
(3) 2 parts ofhybridization solution and 3 parts o fPTW 
(4) 1 part ofhybridization solution and 4 parts o fPTW 
The egg chambers were further washed twice for 20 minutes in PTW at room 
temperature . Al l subsequent steps were done at room temperature. 
Non-specific binding sites of the egg chambers were blocked twice for 20 
minutes using PBT (PBS, 0.1 % BSA, 0.2 % Triton X-100). A 1:5000 dilution of 
alkaline phosphatase (AP)-conjugated goat anti-DIG antibody in PBT was added. 
After incubation for one hour, the egg chambers were rinsed four times for 20 
minutes in PBT. Before staining, the egg chambers were washed three times for 5 
minutes in AP buffer (100 mM Tris-HCl, pH 9.5, 100 mM NaCl, 50 m M MgCl2). 
NBT(0.45 % v/v; 0.34 mg /ml) and X-phosphate(0.3 % v/v; 0.15 mg /ml) (both 
supplied with the kit) in AP buffer were used for the color development of the AP 
60 
i 
reaction. The optimal time for staining was approximately 90 minutes. The staining 
I reaction was stopped by washing the egg chambers several times in PBS and the 
egg chambers were dehydrated by quickly rinsing through a series of ethanol 
solutions (30%, 50%, 70% and 100%) before mounting onto slides using G M M 











Distribution of bcd mRNA in wild type 
The spatial and temporal distribution of bcd mRNA was essentially the same 
as those described by St. Johnston et al. (1989). In the wild type ovaries, hcd 
mRNA first appeared at stage 6 in which it was accumulated at the oocyte (Figure 
2.5A). Through stage 7 to 9, bcd mRNA was confined in the anterior margin of the 
oocyte. At stage 9 and lOA, localization of bcd mRNA was observed both at the 
anterior margin of the oocyte and at the apical regions of the nurse cells. The 
localization was tightly restricted to the anterior margin at stage 10A oocyte. 
Distribution of bcd mRNA in exu'^ mutant 
In the exu^ mutant, distribution of bcd mRNA seemed to be similar to the 
wild type from stages 6 to 8. Beginning from stage 9, bcd mRNA was localized at 
the anterior margin of the oocyte but the localization appeared as diffused (Figure 
2.5A). At stage lOA, a critical difference was observed that bcd mRNA was not 
localized to the anterior margin but rather formed a gradient that diffused from the 
anterior to the posterior within the oocyte. In addition, bcd mRNA was distributed 
evenly in the nurse cells where apical localization was not observed. 
Distribution of bcd mRNA in deletion mutants 
In the rescue mutant, A442-503, localization of bcd mRNA was comparable 
to that of the wild type. The bcd mRNA first appeared in the oocyte at stage 6 and 
was confined at the anterior margin from stage 7 through stage 9 (Figure 2.5A). At 
stage 1 OA, it was tightly localized at the anterior margin of the oocyte and was also 
localized in apical regions of the nurse cells. 
For all other deletion mutants, bcd mRNA was not tightly localized at the 
anterior end of the oocyte. Based on the distribution pattern of bcd mRNA, these 
mutants could be divided into two groups. In mutants A302-375, A374-388, A390-
440 and A426-531, low level of bcd mRNA was localized in the oocytes from 
.] 
丨 stages 6 to 8 (Figure 2.5B). However, bcd mRNA was localized at the anterior end 
of the stage 9 oocyte but appeared to be much more diffused in comparison with 
62 
.i ] 
the wild type. At stage lOA, the distribution of bcd mRNA was uniform within the 
oocyte but a higher concentration of bcd niRNA was observed at the anterior end, 
j In the nurse cells, localization of bcd mRNA at the apical regions of the nurse cells 
was observed but the level of localization vvas much lower than that in the wild 
type, and most of bcd mRNA remained evenly distributed in the nurse cells. 
The third group of distribution pattern included mutants A54-l93, A194-375 
and A390-531, which showed very similar distribution patterns of bcd niRNA. From 
stages 6 to 8, little localization of bcd mRNA was observed in the oocytes (Figure 
2.5C). At stages 9 and lOA, uniform distribution of bccJ mRNA was observed in the 
oocyte as well as in the nurse cells, and higher concentration at the anterior end of 













































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Deletion analysis of the exu protein has demonstrated that the deletion of 62 
amino acid residues in mutant A442-503 was dispensable for function. This mutant 
could provide all the in vivo functions of the wild type exu. In the rescue assay, the 
mutant A442-503 could rescue the maternal-efFect lethality as well as the sterility of 
homozygous exu'\ By immunohistochemical staining and in situ hybridization, this 
mutant exhibited the same spatial and temporal distribution o f both exu protein and 
bcd mRNA as those of the wild type during oogenesis. Thus this mutant was 
indistinguishable from the wild type with respect to both phenotype and function. 
For the other seven deletion mutants, none of them could rescue the 
maternal-efFect lethality of homozygous exu \ Therefore, they did not complement 
the protein null exu'^ allele in providing the in vivo functions o f the wi ld type exu. 
Theoretically, loss-of-function mutations reflect the presence of functionally 
important regions within the deleted protein sequence. Thus, almost the entire 
coding sequence, except for the 62 amino acid residues deleted in mutant A442-
503, seemed to be functionally important. However, the loss o f function of the 
deletion mutants might not be totally due to the removal of functional domain(s) but 
w 
could involve domains not directly responsible for function. Domains responsible 
for maintaining the correct conformation of the functional domain(s) were perhaps 
disrupted in the deletion mutants. Alternatively, stability of the protein was also 
possibly affected. The PEST domain, which was speculated to confer rapid 
proteolysis, was found in the C-terminal region of exu protein. The PEST sequence 
was removed or partially deleted in four of the deletion mutants (Table 2.3) and the 
stability of these mutant exu proteins might have been altered. Nonetheless, the 
rescue mutant A442-503 had over half of the PEST sequence removed. Therefore, 
the PEST domain seemed to be not necessarily important for the function of exu 
protein. Furthermore, it is noteworthy that one of the non-rescue mutants, A374-
388 had a deleted region consisting of only five amino acid residues (3 % of the foll 
length exu). These amino acid residues might account for important function or 
provide essential structural information necessary for the maintenance of the 
functional domains. 
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The non-rescue mutants exhibited altered patterns of spatial and temporal 
distribution of both exu protein and bcd mRNA. Al l of them had lost the tight 
localization of bcd mRNA both at the anterior end of the oocyte and at the apical 
region of the nurse cells in stage 10A egg chambers, suggesting that the absence of 
rescue activity in these mutants was due to the defects in bcd mRNA localization. 
Based on the distribution pattern of bcd mRNA, the non-rescue deletion mutants 
could be divided into two groups. One group of mutants, A302-375, A374-388, 
A390-440 and A426-531 had localization of bcd mRNA at the anterior end of the 
oocyte but the localization was quite difibsed in stage 9 egg chambers. At stage 
10A oocytes, bcd mRNA was distributed homogeneously within the oocyte and the 
nurse cells, despite higher levels of bcd mRNA were present at the anterior margin 
of the oocyte and the apical regions in the nurse cells. This partial localization of 
bcd mRNA suggested that some of the functions of exu protein might be retained in 
these mutants. On the other hand, the distribution pattern of exu protein in these 
four mutants were not quite similar, at least at the late stages (lOA). In mutants, 
A302-375 and A374-388, localization of exu protein in the oocytes was observed 
between stages 6-8, although the level of localization was much lower than that of 
the wild type. Beginning at stage 9, localization of exu protein in the apical regions 
of the nurse cells was observed and exu protein was almost exclusively found in the 
nurse cells at stage 10A egg chambers (Table 2.4). The other two mutants, A390-
440 and A426-531, also had localization of exu protein in the oocytes between 
stages 6-8 but no apical localization in the nurse cells of the stages 9 and 10A egg 
chambers (Table 2.4). Besides, the level of exu protein in the stages 10A egg 
chambers was much lower than that of mutants , A302-375 and A374-388. 
In the other three non-rescue mutants, A54-193, A194-375 and A390-531, 
bcd mRNA was uniformly distributed but a higher level of bcd mRNA was found at 
the anterior end of the oocyte in stage 10A egg chambers. The failure of 
localization would be due to the absence of localization of exu protein in mutant 
A54-193 and to the stability of the protein in the other two mutants . The large 
sequence deletions in these three mutants might have led to instability of the mutant 
protein. The deleted regions accounted for more than 25 % of the full length protein 
in the three mutants (Table 2.5). Low level of expression in mutant A54-193 and 
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even absence of detectable exu protein in mutants A194-375 and A390-531 
supported the fact that the protein expression was greatly affected. The large 
deletions in coding sequence would possibly affect the expression in both the 
transcriptional and translational levels. The resulting mRNA and polypeptides 
would lack essential structural elements for maintaining their structure and stability 
and thus no protein could be accumulated to the detectable level. 
By comparison of the spatial and temporal distribution of exu protein and 
bcd mRNA among the eight deletion mutants (Table 2.4), it was obvious that the 
non-rescue mutants differed from the rescue mutant in loss of localization of exu 
protein at early stages (stages 1-5) and failure of localization of bcd mRNA at late 
stages. Thus exu protein of the non-rescue mutants might have lost certain 
functional domains necessary for its localization at the early stages, and this early 
localization was critical for subsequent localization of bcd mRNA at late stages. 
Therefore, the localization of exu protein at early stages would play a significant 
role in bcd mRNA localization. 
In addition, among the deletion mutants, the localization of exu protein can 
be distinguished into three phases. The first phase was the localization of exu 
protein in the oocytes at stages 1-5, which was only observed in the rescue mutant 
(A 442-503). The second phase was the localization in the oocytes at the mid-
oogenesis (stages 6-8) and the third phase was found at stages 9 and 10A in which 
exu protein was gradually excluded from the oocyte and concentrated in the apical 
regions of the nurse cells. The different phases of exu localization reflects the 
presence of different potential functional domains regulating its localization at 
different stages. Three different potential domains of exu protein may be responsible 
for directing its localization at early stages (stages 1 to 5), mid-oogenesis (stages 6 
to 8) and late stages (stages 9-10A). Alternatively, the three domains may work 
cooperatively as a single functional unit to direct the exu localization. The 
localization directed by these potential domains in turn confers bcd mRNA 
localization at different stages. In the rescue mutant, all three domains must have 
been retained and thus anterior localization of bcd mRNA was observed at both 
stage 9 and stage 10A (Table 2.4). In the non-rescue mutants (A 302-375, A374-
388, A390-440 and A426-531), the second domain might have been preserved as 
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anterior bcd mRNA localization was only found in stage 9 but not in stage 10A 
(Table 2.4). Thus the potential functional domains may confer bcd mRNA 
localization in a stepwise manner - the first domain is responsible for the 
localization of stage 10A while the second domain is sufficient to confer localization 
only at stage 9. 
Based on the assumption that different domains of exu direct localization of 
bcd mRNA at different stages, several regions of the coding sequence of exu 
seemed to confer different functions (Figure 2.6). A region starting from amino acid 
residues 54 to 193 would be important for the localization of bcd mRNA in both 
stages 9 and lOA, as removal of this region resulted in loss of the localization. The 
other two regions, amino acid residues 302-442 and 503-531, would be responsible 
for conferring localization in stage 1 OA, since mutants having deletions within these 
two regions lost their localization of bcd mRNA in stage 10A but not in stage 9. 
Thus all the three regions appeared to be essential for the bcd mRNA localization. 
In addition, deletion of two regions which spanned amino acid residues 194-375 
and 390-531 resulted in absence of detectable exu protein. These regions would be 
necessary for maintaining the stability of exu protein. Alternatively, the regions 
affecting the bcd localization might be also important for the stability of the protein, 
as lower level of protein was detected in some of the mutants (A54-193, A390-440 
and A426-531). However, this model may be oversimplified as the functional 
domains of exu are likely to exist in three-dimensional conformation. Tertiary 
structure of the protein may bring different regions of the coding sequence into a 
specialized conformation. Thus the three different regions conferring the bcd 
mRNA localization might represent different parts of a single functional unit and all 
of them may be required for the full activity of exu. 
The experimental results suggested a possible mechanism of how exu 
protein assists in localization of bcd mRNA. As the localization of exu protein at 
the early stage oocytes seems to be important functionally, certain localization 
signals may be deposited in the early oocytes by exu protein to direct the 
localization of bcd mRNA at late stages. Direct interactions between exu protein 
and bcd mRNA are not necessary in this model. Rather, additional components may 
be essential for their indirect linkage in which they receive signals from exu protein 
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and then transmit the signals to other components necessary for the localization. In 
this model, two unknown components have not been identified yet. The first is the 
one which initiates exu protein to transmit the localization signals and the second is 
the one which receives the signals from exu protein. In combination to the model 
proposed by Lane and Kalderon (1994), the first component is thought to be 
resided within the posterior polar follicle cells, whose position readily provides an 
asymmetry to the oocyte. A signal is initiated in the posterior polar follicle cells by 
activating a germ line protein kinase A (PKA) within the oocyte which then 
phosphorylates a target protein to further transmit the signal. The target protein 
remains uncertain but is speculated to be a MAP2 like protein which regulates the 
organization of microtubules within the oocyte (Sloboda et al., 1975; Theurkauf 
and Vallee, 1982; reviewed by Lane and Kalderon, 1994). The microtubules can 
then reorganize in mid-oogenesis and allow the anterior localization of bcd mRNA 
(reviewed by Lehmann,1995; Anderson, 1995). Based on the experimental data, the 
target protein could possibly be exu protein. Several pieces of evidence support this 
speculation. Firstly, exu protein is absolutely required for localization of bcd 
mRNA. Either lack of this protein or deletion of part of the protein would perturb 
localization of bcd mRNA. Secondly, exu protein is already localized in the oocyte 
at the early stages of oogenesis, reflecting a possibility of being phosphorylated by 
PKA within the oocyte. Another strong evidence is that exu is a phosphoprotein. 
The phosphorylation of exu protein is expected to be at multiple sites as at least 
four closely spaced major isoforms could be revealed by western blot analysis. Exu 
protein from the ovary extracts could be phosphorylated by several protein kinases 
including PKA (Cheung et al., unpublished data, manuscript in preparation). Hence 
the exu protein would possibly be a candidate of phosphorylation by PKA in the 
oocyte. 
The phosphorylation of exu protein may be critical for its function to 
localize bcd mRNA. In the rescue mutant, A442-503, certain modification of exu 
protein was observed as two bands were revealed by western blot. The modification 
would probably be phosphorylation. No such observation was seen in the non-
rescue mutants. 
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The component which received the localization signal from exu protein 
would probably be microtubules. Microtubules were found to be essential for 
localization of RNAs, bcd mRNA and osk mRNA in the oocyte (Pokrywka and 
Stephenson, 1991, 1994; Lane and Kalderon, 1994) and were reorganized just prior 
to localization ofthese RNAs (St. Johnston et al. 1989, 1991; Ephrussi et al. 1991; 
Kim-Ha et al. 1991). At early stages, a microtubule-organizing center (MTOC) was 
postulated to position at the posterior of the oocyte, sending microtubules toward 
the anterior and into nurse cells through cytoplasmic bridges (Theukauf et al., 1992, 
1993; reviewed by Cooley and Theurkauf, 1994; St Johnston, 1995). The MTOC 
persists at the posterior until stage 6. By stage 7, the signals transmitted by PKA 
promotes degeneration of the posterior MTOC. At the same time, a new 
microtubule nucleating center appears at the anterior margin extending microtubules 
towards the posterior. Thus a uniform polarity of microtubules can be established 
for the localization of bcd mRNA. 
The above model involves the initiation of a signal from the posterior polar 
follicle cells and the transmission of this signal through PKA to exu protein, and 
finally the destabilization of the posterior MTOC in the oocyte. However, this 
model is clearly incomplete. I f the signal is transmitted through this single pathway, 
the observation of abnormal localization of bcd mRNA at both ends and osk mRNA 
at the middle of the oocyte in the PKA mutant wil l be expected to be seen in exu 
mutants. However, no transient localization of bcd mRNA at the posterior of the 
oocyte was observed in either exu'^ mutant or the exu deletion mutants. Thus the 
signaling pathway will not be a simple one but involve interactions with more 
components or pathways. 
Nonetheless, according to the above model, exu protein will be expected to 
interact with microtubules in order to complete the signaling pathway. Hence, 
characterization of the associations between exu protein and microtubules would 
provide further insight into the mechanism of bcd mRNA localization. 
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Table 2.3 Deletion of the PEST domain in the deletion mutants 
Deletion mutants Rescue Percentage ofPEST deleted 
A390-440 - 34 % 
A442-503 + 56 % 
A426-531 - 100 % 
A390-531 - 100 % 
Table 2.4 Comparison between the localization of exu protein and bcd mRNA 
in the deletion mutants 
Deletion mutants Localization of exu protein Localization of bcd mRNA 
stages 1-5 stages 6-8 stages 9-lOA stage 9 stage 10A 
non-rescue mutants 
A302-375 _ +# + + * _** 
A374-388 一 + # + + * _ * * 
A390-440 _ +# _ + * J * 
A426-531 _ +# _ +•^ ? * 
A54-193 - _ _ . _ 
A194-375 - - _ _ _ 
A390-531 - _ _ _ _ 
rescue mutant 
A442-503 + + + + + 
# The level of localization in the oocytes was much lower than that of the rescue mutant. 
* Only partial localization of bcd mRNA was observed. At stage 9, bcd mRNA was localized at 
anterior end of the oocyte but the localization appeared diffused. 
** At stage lOA, bcd mRNA was distributed evenly but higher level of it was observed at anterior 
end of the oocyte and apical regions of the nurse cells. 
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Table 2.5 Percentage of deletion in the coding sequence of the deletion 
mutants 
Deletion mutants Rescue Percentage of sequence 
deletion 
A54-193 - 26 % 
A194-375 - 34 % 
A302-375 - 14 % 
A374-388 - 3 % 
A390-440 - 10 % 
A442-503 + 12 % 
A426-531 - 20 % 
A390-531 - 27 % 
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Full coding sequence of exu 
1| I 531 
5 4 _ _ i _ _ _ _ i i _ _ 1 9 3 
194 y / / / / / / / / / / / / / / / / / A 375 
3 0 2 ^ ^ ^ H 3 7 5 
374圃 388 
3 9 0 i ^ 4 4 0 
442|.----------i 503 
4 2 6 H H ^ H 531 
z^^YZZZZZZZZZZZZZA 531 
j:iiiii;i:l Deletion resulted in loss of bcd localization in stages 9-1 OA 
^ ^ M Deletion resulted in loss of dcdlocalization in stage 10A 
X / / / A Deletion resulted in instability of protein 
~----'-~-\ Region not essential for protein function 
Figure 2.6 Potential functions of different regions of the exu 
coding sequence. 
By deletion analysis, several regions of the coding sequences were 
found to confer different functions. Region of 54-193 amino acid 
residues seemed to important for localization of bcd mRNA in both 
stages 9 and lOA, while regions 302-442 and 503-531 amino acid 
residues were responsible for localization at stage lOA. Another two 
regions, which partially overlapped to the above regions, conferred 
stability of the protein. 
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CHAPTER 3 
Determination of the interactions between exu and 
microtubules 
3.1 Introduction 
Microtubules have been demonstrated to play an essential role in 
localization of bcd mRNA. Pokrywka and Stephenson (1991) have shown that 
drugs, such as colchicine and taxol, which affect the stability of microtubules, 
disrupted the localization of bcd mRNA. They have further demonstrated that both 
bcd mRNA and exu protein are associated with a detergent insoluble fraction in the 
ovary extracts and the association can be released by microtubules destabilizing 
drugs (Pokrywka and Stephenson, 1994). Evidence of the dependence of 
localization of bcd mRNA on microtubules has been provided by the study of 
protein kinase A (PKA) mutations. Lane and Kalderon (1994) have characterized 
germ line PKA deficient mutants which disrupt both microtubules organization and 
RNA localization in the developing oocyte. In normal oocytes of stages 7 to 8，a 
microtubule organizing center (MTOC) is located at the anterior, establishing a 
uniform polarity of microtubule framework in which minus ends of microtubules are 
located at the anterior while plus ends are extending toward the posterior 
(Theurkarf et al., 1992). In this microtubule network, bcd mRNA is localized at the 
anterior pole while osk mRNA is localized at the posterior pole of the oocyte. 
However, in the PKA mutant, microtubule nucleating regions are located at both 
anterior and posterior poles, creating a network of microtubules with their minus 
ends situated at both anterior and posterior poles and their plus ends extended into 
middle of the oocyte. The abnormal localization of bcd mRNA at both poles and 
osk mRNA at the middle of the oocyte can be observed in the mutant. Thus, the 
distribution ofRNAs is closely related to the polarity of microtubules whereby bcd 
mRNA is always localized at the minus ends while osk mRNA is always localized 
towards the plus ends of microtubules. This observation suggests that hcd mRNA is 
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transported by minus-end directed motors while osk mRNA is associated with plus-
end directed motors (Ruohola et al., 1991; Clark et al., 1994; Lane and Kalderon, 
1994). 
As exu is associated with microtubules (Pokrywka and Stephenson, 1994) 
and is required for the localization of bcd mRNA (St. Johnston, et al., 1989), it is 
conceivable that exu protein may assist in localization o f bcd mRNA through 
interactions with microtubules. Several approaches were used to characterize the 
interactions between exu protein and microtubules. The first analysis aimed at 
determining the in vivo dependence of distribution of exu protein on cytoskeleton 
based on pharmacological and cytological evidence (section 3.2). Further analysis 
intended to establish the biochemical evidence of the interactions. In section 3.3, 
the direct interactions between exu protein and microtubules were analyzed by 
immunoprecipitation. Sections 3.4 to 3.7 were experiments based on a 
cosedimentation approach, which depended on the affinity of microtubule-
associated proteins (MAPs) to microtubules and the cosedimentation of these 
protein complexes. This cosediemntation approach was modified and refined and 
consequently, the method in section 3.7 has successfully determined that exu is，by 
definition, a MAP. 
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3.2 Localization of bcd mRNA and exu protein in the presence of 
drugs which destabilize cytoskeleton 
To determine the in vivo dependence of localization o fbo th bcd mRNA and 
exu protein on cytoskeleton, drugs which destabilize cytoskeleton were directly 
injected into the abdomen of wi ld type female flies and any alteration o f the spatial 
and temporal distribution of bcd mRNA and exu protein were analyzed by in situ 
hybridization and immunohistochemical staining, respectively. 
3.2.1 Materials and Methods 
Stocks of colchicine was dissolved in absolute ethanol at a concentration of 
20 mg/ml and cytochalasin D was dissolved in absolute ethanol at a concentration 
of 2 mg/ml. For injection, colchicine was diluted to 200 ug/ml in PBS and 
cytochalasin D was diluted to 20 ug/ml in PBS. Mock control was performed by 
injection of 1 % ethanol in PBS. A range of drug concentrations were used to 
ensure that the drug concentration was not limiting. A commercially available food 
dye solution was added to 10 % (v/v) to allow observation of the injection process. 
This ensured that the flies were properly injected as their abdomens took up the 
dye. The resulting dmg solution was loaded into a microinjection needle and 
approximately 100 nl of dmg solution was injected into the abdomen of each fly. 
The injected flies were allowed to recover for 17 to 20 hours at 25°C. Ovaries from 
flies were collected for immunohistochemical staining and in situ hybridization. The 
vials which contained the injected flies were incubated for fourteen days to 
determine the viability of their eggs. 
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3.2.2 Results 
Adult flies were observed to emerge from the vials of the mock control and 
the cytochalasin D injection (drug concentration 20 ug/ml). These flies were healthy 
and normal without any observable morphological difference from the wi ld type. In 
contrast, no adult fly was emerged from eggs laid by the colchicine injected flies. 
Eggs were observed in the vials but none of them hatched into larvae. 
The localization of exu protein in the mock treated egg chambers was 
indistinguishable from the wild type (Figure 3.1A). Exu protein was found to 
concentrate in oocytes of stage 2 up to stage 8 and to accumulate in apical regions 
of the nurse cells of stage 9 and 10A egg chambers. Therefore, the injection with 
1% ethanol seemed to have no effect on the localization of exu protein. 
The localization of exu protein was completely abolished in the colchicine 
treated egg chambers (Figure 3.1A). No localization of exu protein was observed at 
all stages of egg chambers (from germarium up to stage 9). In addition, neither 
stage 10A nor older egg chamber was found; only disintegrated egg chambers of 
comparable size to stage 10 egg chamber were seen. The early egg chambers 
seemed to also have a certain degree of disintegration in which the layer of follicle 
cells surrounding the oocyte were not complete (Fig. 3.1A, indicated by arrows). In 
these egg chambers, the effect of colchicine was not restricted the developing 
oocyte, but extended to the follicle cells. The stability of microtubules in the follicles 
cells may also have been affected, causing the discontinuous follicle cell layer at the 
early stages and even severe disintegration at the late stages (stage lOA). 
The localization of exu protein was unaffected in the cytochalasin D treated 
egg chambers as comparing to the mock control. A range of drug concentration, 20, 
40, and 80 ug/ml, was used to inject flies but there was no effect on the spatial and 
temporal distribution of exu protein. Thus, cytochalasin D seemed to have no effect 
on the localization of exu protein and hence actin filaments were not necessary for 
the localization. 
Using in situ hybridization techniques, the temporal and spatial distribution 
of bcd mRNA was analyzed in the drug-treated egg chambers. Localization of bcd 
mRNA was completely abolished in the colchicine-treated egg chambers (Figure 
3.1B). The bcd mRNA was uniformly distributed in all stages of egg chambers. The 
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anterior localization in the oocyte was not seen from stages 6 to 9. As most of the 
stage 10A egg chambers tended to be disintegrated, the distribution of bcd mRNA 
was not detectable at stages older than stage lOA. 
In the mock-treated and the cytochalasin D treated egg chambers, the 
distribution of bcd mRNA were similar to that of the wild type (Figure3.1B). 
Anterior localization at the oocyte was observed from stages 8 to 10A as well as the 
apical localization in the nurse cells in stage lOA. Therefore, cytochalasin D did not 






















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































3.3 Analysis of interactions between exu and microtubules by 
immunoprecipitation 
The direct interaction between exu and microtubules was determined by 
incubating microtubules with exu protein which was isolated by 
immunoprecipitation in ovary homogenate. I f direct binding occurred, microtubules 
would bind to the immunoprecipitation complex; otherwise, microtubules would 
remain unbound in the homogenate. The immunoprecipitation complexes were then 
analyzed for any associated microtubules by western blot analysis. 
3.3.1 Materials and Methods 
3.3.1.1 Immunoprecipitation of exu protein and binding ofmicrotubuIes 
Forty to fifty pairs of ovaries were isolated from two-day-old female flies in 
PBS. The ovaries were washed and homogenized with a disposable pestle in a 
microcentrifuge tube containing 0.5 ml of ice-cold RJPA buffer (150 mM NaCl, 50 
mM Tris-HCl, pH 8.0, 1 mM EDTA, 1 % NP40, 0.5 % DOC, 0.1 % SDS, 1.0 
ugAnl pepstatin, 1.0 ug/ml leupeptin, 1.0 ug/ml aprotinin, 0.28 m M PMSF). The 
homogenate was transferred to a pre-chilled polypropylene tube. One milliliter of 
RJPA buffer was used to wash the microfuge tube and was pooled with the 
homogenate. The homogenate was sonicated on ice 3 times for 3 bursts at 10 s 
each. It was then divided into six 250 ^il aliquots. For immunoprecipitation of exu 
protein, one aliquot of ovary homogenate was precipitated by incubating with 3 ^il 
of anti-exu antibody for 2 hours and then with 50 ^il of 10 % Pansorbin or Protein 
G-agarose (Calbiochem) for 90 minutes at 4°C with agitation. Ajfter the adsorption, 
the antigen-antibody (Ag-Ab) complex was collected by centrifugation at 4°C and 
was washed with 1 ml RJOPA. The washing and centrifugation steps were repeated 
three more times. The final Ag-Ab complex was then washed and equilibrated in 
PM buffer (0.1 M PEPES, 2 mM EGTA, 1 mM MgSO4, 2 mM DTT) three times for 
5 minutes. The Ag-Ab complex in 0.5 ml PM buffer was supplemented with 20 uM 
taxol and 0.5 mM GTP and then with 0.2 mgAnl of taxol-stabilized microtubules. 
After incubation for 30 minutes at room temperature, the Ag-Ab complex was 
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recovered by centrifugation and washed three times in PM buffer for 10 minutes 
while the supernatant was acetone-precipitated by adding of 2 volumes of ice-cold 
acetone and incubating for 1 hour on ice. Both of the Ag-Ab complex and the pellet 
of acetone-precipitated supernatant were resuspended in 25 ^il of SDS sample 
buffer and analyzed by Western blot analysis. Two duplicated blots were produced. 
One blot was detected with a rabbit anti-exu antibody and then an AP-conjugated 
goat anti-rabbit antibody. The other was detected with a mouse monoclonal anti-P-
tubulin antibody (Boehringer) and then an AP-conjugated anti-mouse antibody 
(Tropix) as the secondary antibody. 
3.3.1.2 Purification of tubulin from bovine or rat brains 
Tubulin was purified by a twice-cycled polymerization-depolymerization 
protocol described by Williams (1992). Bovine or rat brains were minced into small 
pieces in PM buffer on ice and then washed two times in the same buffer. Using a 
30 ml-glass homogenizer with a telfon pestle, the brains were homogenized in 30 ml 
o f P M per 100 g of tissue on ice. Al l subsequent steps were performed at 4°C. The 
homogenate was clarified by centrifugation at 6,500 x g for 15 minutes in a JA-20 
rotor in a Beckman J-2 MC centrifuge. The supernatant was decanted and 
centrifuged again at 96,000 x g for 75 minutes in a TLA-120.2 rotor in Beckman 
Optima TLX Tabletop Ultracentrifuge or a Type 42.1 rotor in a Beckman L7-55 
Centrifuge. The supernatant was saved and an equal volume o fPM-8M (PM buffer, 
8 M glycerol) was added to make a final concentration of 4M of glycerol. In order 
to promote microtubules formation, the supernatant was supplemented with a final 
concentration of 1 mM GTP and 2.5 mM ATP and incubated for 45 minutes at 
34°C. ( A high concentration of ATP was required to inhibit the binding of motor 
proteins to microtubules). After centrifugation at 96,000 x g for 60 minutes at 
30°C, the supernatant was discarded and the pellet, which contained microtubules, 
was resuspended in 1/4 of the original volume ofPM. The pellets were subjected to 
five gentle strokes in a Dounce homogenizer to produce a uniform suspension. The 
suspension was incubated for 30 minutes on ice to allow microtubules 
depolymerization. Centrifugation at 96,000 g for 60 minutes at 4°C resulted in 
tubulin subunits in the supernatant and un-depolymerized microtubules as well as 
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impurities in the pellet. The supernatant was saved and added with an equal volume 
o fPM-8M to make a final concentration of 4M of glycerol. Then a second cycle of 
polymerization, centrifugation, depolymerization and centrifiigation was carried out 
by repeating the above steps. After the depolymerization and centrifugation, the 
supernatant, referred to as twice-cycled microtubule protein, was saved and stored 
in aliquots at -70°C as stocks of tubulin. 
3.3.1.3 Determination of protein concentration of the tubulin stock by Folin-
Lowry method 
The protein determination method was adapted from Lowry et al. (1951). A 
volume of 0.1 ml protein sample was added with an equal volume of 2 N NaOH. 
Another set was made by BSA of known concentrations as standards. After a 30 
minute incubation period at room temperature, serial dilutions of the denatured 
protein samples were made by diluting with 1 N NaOH. Each dilution was mixed 
with 1 ml of Reagent A (prepared fleshly by mixing 100 ml 2 % Na2CO3, 2 ml 1 % 
CuSO4 and 2 ml 2 % K-Na tartrate) and incubated for 10 minutes. Each dilution 
was added with 100 ^il of 1 N of folin and vortexed immediately. The absorbance at 
OD750 was determined spectrophotometrically between the period of 20 and 45 
minutes after the addition of folin. A BSA standard curve was established and the 
concentration of the protein was read from the plot. 
3.3.1.4 Taxol-stabilized microtubules 
Microtubules were polymerized from tubulin subunits by the method 
described by Arshad Desai (personal communication) . Tubulin stock was diluted to 
2 mg/ml in PM buffer and supplemented with 1 mM GTP on ice. The formation of 
microtubules from tubulin was promoted by high temperature and a serial addition 
of taxol. The diluted tubulin was warmed to 37 °C and supplemented with 1/100 
volume of 0.02 mM taxol in DMSO. After incubation for 5 minutes, an additional 1/ 
100 volume of 0.2 mM taxol in DMSO was added and incubated for 5 minutes. The 
final concentration of taxol was made to about 20 uM by further addition of 1/100 




Among the four sets of immunoprecipitation complexes, exu protein was 
only found in the wild type ovary extracts (lane 1，Figure 3.2A), although the 
amount was low. I f microtubules have bound to exu protein, tubulin would be 
expected to be present only in the immunoprecipitation complex of the wild type 
ovary extracts. However, microtubules were found to bind the immunoprecipitation 
complex nonspecifically as tubulin bands were present in all the lanes including 
those controls without exu protein (Figure 3.2B). Tubulin was found to be present 
in the Ag-Ab complex independent of the types of extracts (the wild type, lane 1 ； 
exu^ ovary extract, lane 2, Figure 3.2A,B). In addition, the microtubules was most 
likely bound to the protein G-agarose as tubulin was also present at the protein G-
agarose only complex (lane 4, Figure 3.2A,B). Therefore, this immunoprepicitation 







E o ^ 
Mr g "3 2 
^ V •編 
s 0 5 1 2 3 4 
_ 旧 f ：:I . -
？ '* ift^、 ” r ^ 
1 7 5 . 0 ^ 
8 3 . 0 • ‘ »» 鳾 
62.0 • 麵 
〜||||塵 
^ ^ K ^ ^ M ^ ^ 1 " ^ ^ anti-exu 
iii 
* _ 播 *• .',、 
• -
i 
3 2 . 5 • 
•••• -^-r^ TT- - • ’ , - : 
Figure 3.2 Detection of exu protein and microtubules in the 
immnuoprecipitation complexes. 
A . Wes te rn blot analys is of exu protein in immunoprec ip i t a t ion complexes . Mul t ip le i so forms of 
exu protein can be detected in the wild type ovary extracts . A s a nega t ive control , the ovary 
ext rac ts o f t h e exu"c protein null mutan t w a s run in paral lel wi th that o f t h e wi ld type. T h e a r row 
indicates the posi t ion of the rabbit ant i -exu an t ibody that w a s de tec ted by the A P - g o a t ant i - rabbi t 
an t ibody . 
Lane: exu^c, ovary extracts of the protein null mutan t ; wi ld type, ovary ext rac ts o f t h e wi ld type; 
1, immunoprec ip i t a t ion complex m a d e by incubat ing wi ld type extracts , ant i -exu an t ibody(Ab) , 
prote in G-aga rose (G) ; 2, immunoprec ip i ta t ion c o m p l e x m a d e by incubat ing e x u ^ extracts , Ab , 
G ; 3 , immunoprec ip i ta t ion complex m a d e by incubat ing A b and G only , no extracts; 4, 
immunoprec ip i t a t ion complex m a d e by incubat ing G only, wi th nei ther extracts nor Ab . All 
immunoprec ip i t a t ion complexes w e r e supp lemented with micro tubules . 
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Figure 3.2 Detection of exu proteinin and microtubules in the 
immnuocomplexes. 
B . W e s t e r n blot ana lys i s o f tubu l in in I m m u n o p r e c i p i t a t i o n c o m p l e x e s . A dup l i ca t ed 
b lo t o f F i g u r e 3 .2A w a s de t ec t ed by an t i -P - tubu l in an t ibody . M i c r o t u b u l e s w e r e 
d e n a t u r e d into tubu l in m o n o m e r s on S D S P A G E and tubu l in w a s de tec ted as a 
m o l e c u l a r w e i g h t o f 55 ( ind ica ted by a r row) . 
L a n e : tubulin, pu r i f i ed tubu l in w a s run a l o n g s i d e as a marke r ; 1-4，see F i g u r e 3 .2 A, 
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3.4 Analysis of interactions between exu and microtubules by 
cosedimentation 
The sedimentation characteristics of microtubules (Weisenberg, 1972; 
Shelanski, et al., 1973), can be used to determine potential interactions between exu 
protein and microtubules. This was achieved by incubation of ovary extracts with 
microtubules and by centrifugation to co-sediment microtubules and microtubule 
associated proteins (MAPs) (Figure 3.3). MAPs were first described as proteins that 
co-purified with tubulin during repetitive cycles of assembly and disassembly 
(Borisy et al., 1975; Wiche, 1989). In addition, some associated proteins display 
transient interactions with microtubules, such as motor proteins are usually 
classified as microtubule binding proteins (MTBPs) (Richard and Kreis, 1991). The 
method was originally used for the isolation of MAPs and hence exu could be 
classified as a MAP i f the cosedimentation of exu protein and microtubules 
occurred. 
3.4.1 Materials and Methods 
The method was adapted from several microtubule and MAPs 
cosedimentation protocols (Yang et al., 1989; Aizawa et al., 1991; Rickard and 
Kreis, 1991; Michalik et al., 1993; Hays, et al., 1994; Li, et al., 1994; Walczak, et 
al., 1996), with the following modifications. About 80 pairs ofovaries were isolated 
from female flies and washed in PM buffer. The ovaries were homogenized with a 
dounce homogenizer in 1 ml o f P M buffer. The ovary homogenate was first clarified 
by centrifugation at 37,000 r.p.m. for 30 minutes in a Beckman TLA-120.2 rotor. 
The supernatant was decanted and supplemented with 0.5 mM GTP and protease 
inhibitors (1 ug/ml pepstatin A, 1 ug/ml leupeptin, 1 ugAnl aprotinin) before 
warming up to room temperature. The extract was added with 5 uM of taxol in 
DMSO and incubated for 5 minutes at 34。C. An additional 15 uM taxol was added 
and the extract was further incubated for 10 minutes. Taxol-stabilized microtubules 
were supplemented to a final concentration of 0.2 mg/ml and the binding was 
allowed at 34°C for 30 minutes. By loading the extracts onto 1 ml o f30 % glycerol 
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cushion in PM buffer with 10 u M taxol and protease inhibitors, the microtubules 
was collected by centrifugation at 33,000 r.p.m. for 45 minutes in a Beckman TLS-
55 swinging bucket rotor. The pellets were collected while the supernatants were 
concentrated by acetone precipitation. Both the pellets and supernatants were 
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Figure 3.3 Basic principle of characterization and purification of 
MAPs by cosedimentation 
Ovary extracts are incubated with microtubules and MAPs bind on 
microtubules while other proteins including free tubulin subunits are 
remained unbound. By centrifugation, microtubules and MAPs can be 
isolated in the pellet leaving other proteins in the supernatant. 
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3.2.2 Results 
I f exu protein were associated with microtubules, it would cosediment with 
microtubules and could be found in the pellet. In the wild type ovary extracts 
supplemented with exogenous microtubules (lane P1, Figure 3.4A), exu protein was 
found in the microtubule pellet. However, the same observation was found in the 
wild type ovary extract without the addition of microtubules (lane P3), although the 
amount of exu protein at lane P3 was much lower than that in lane P1. Therefore, 
the amount of exu protein sedimented was higher in the presence of exogenous 
microtubules. This implied that exu protein was cosedimented with microtubules, 
suggesting their interactions. The presence of a small amount of exu protein in lane 
P3 would be due to the incomplete clarification of the ovary extract during initial 
steps. Alternatively, association of exu protein to the endogenous microtubules 
might be sufficient for sedimenting exu protein. 
In addition, it was noted that most of exu protein was lost in the clarification 
step. The exu protein in the pellet of clarification of ovary extracts (lanes 5) was 
much more abundant than that in lanes P1 and S1. Most of the exu protein was not 
extracted into soluble form but retained in the insoluble fraction of the ovary 
extracts. Thus the homogenization method described here was not sufficient to 
release exu protein. 
As shown in Figure 3.4B, tubulin was found in both the pellets and the 
supernatants. As the assembly of microtubules continued to a steady state at which 
the microtubules mass and the concentration of non-polymerized tubulin subunits 
remained constant (Bayley et al., 1994), microtubules were sedimented while the 
free tubulin subunits remained in the supernatant after centrifugation. The 
abundance of tubulin indicated that the pellet was the result of sedimentation of 
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Figure 3.4 Analysis of exu protein cosedimented with microtubules. 
A f t e r i n c u b a t i o n o f w i th o v a r y ex t rac t , m i c r o t u b u l e s w e r e pe l le ted by c e n t r i f u g a t i o n a n d a n a l y s e d 
f o r c o s e d i m e n t e d e x u pro te in . 
A . W e s t e r n b lo t a n a l y s i s o f e x u p ro t i en c o s e d i m e n t e d w i t h m i c r o t u b u l e s 
L a n e : exu^S w i l d type , o v a r y ex t r ac t s f r o m exu"'c ^nd the wi ld t y p e r e s p e c t i v e l y ; P , S，pellets and 
s u p e m a t a n t s r e su l t i ng from c e n t r i f u g a t i o n a f t e r t he i ncuba t ion o f 1, w i l d t y p e o v a r y ex t r ac t s and 
m i c r o t u b u l e s ( M T ) ; 2 , exu"^ ex t rac t s and M T ; 3，wild t y p e ex t rac t s on ly , n o M T ; 4，MT on ly , no 
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Figure 3.4 Analysis of exu protein cosedimented with microtubules. 
B . Wes te rn blot analysis of tubul in . A dupl ica ted blot o f F igure 3 .4A w a s detec ted by 
ant i -P- tubul in ant ibody. 
Lane : tubul in , pur i f ied tubul in w a s run a longs ide as a marker ; P l - P 4 , S l - S 4 , 5, 6, see 
F igure 3.4 A. 
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3.5 Analysis of interactions between exu and microtubules using 
detergent extracted ovary extract for cosedimentation 
As there were difficulties in extracting exu protein described in the previous 
section (section 3.3), detergents was supplemented to facilitate better solubilization 
of proteins from ovary extracts. The detergent-containing RIPA buffer used in the 
immunoprecipitation protocol was adopted to homogenize ovaries as it was useful 
to release exu protein from the ovary lysate. Followed by dialysis, the homogenate 
was equilibrated with a microtubule-favorable buffer and was supplemented with 
exogenous microtubules for the cosedimentation experiment. 
3.5.1 Materials and Methods 
Ovaries were homogenized in RIPA buffer on ice. The homogenate was 
sonicated three times for 10 seconds and then clarified by centrifogation at 57,000 
r.p.m. for 45 minutes at 4°C in a Beckman TLA-120.2 rotor. A surface lipid layer 
was removed and the supernatant was dialyzed in 1 liter of REPA buffer without 
detergents (150 mM NaCl, 50 m M Tris-HCl, pH 8.0, 1 mM EDTA), plus 0.28 mM 
PMSF, 5 mM NaF, 100 uM Na3VO4, for 4 hours at 4°C. Dialysis was repeated 
once more overnight with a change of fresh buffer and then a final change of buffer 
for 4 hours with BRB80 buffer (80 mM PffES, 1 mM MgCl2, 1 mM EGTA) 
(Walczak et al., 1996; Arshad Desai, personal communication). The extracts was 
kept at -70°C. The cosedimentation procedure has been described in section 3.4.1. 
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3.2.2 Results 
As shown in Figure 3.5A, exu protein was found in both pellets of the wild 
type extracts with (lane P1) and without (lane P3) the addition of exogenous 
microtubules. Therefore, exu protein seemed to be sedimented into the pellets 
independent of the presence of microtubules. However, a higher amount of exu 
protein was sedimented in the presence (lane P1) than in the absence (lane P3) of 
exogenous microtubules suggesting that exu might have interactions with 
microtubules. 
Besides, most ofthe exu protein from the ovary extracts was lost during the 
clarification (lane P5). Thus, exu protein was not released into soluble forms and 
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Figure 3.5 Cosedimentation of exu protein and microtubules using 
detergent extracted ovary lysate. 
O v a r i e s w e r e ex t rac ted in d e t e r g e n t - c o n t a i n i n g b u f f e r and then d ia lysed to e x c l u d e de t e rgen t s 
b e f o r e the c o s e d i m e n t a t i o n e x p e r i m e n t . 
A . W e s t e r n blot ana lys i s of exu pro te in . 
L a n e : w i l d type , ova ry ext rac ts o f t he w i ld type ; P, S, pe l le t s and s u p e r n a t a n t s r e su l t ing f r o m 
cen t r i f uga t i on a f te r the incuba t ion o f 1, wi ld t ype ova ry ex t rac t s and t axo l - s t ab i l i zed 
m i c r o t u b u l e s ( M T ) ; 2，exu"'^ ex t rac ts and M T ; 3, wi ld t y p e ex t rac ts only , n o M T ; 4，MT only , no 
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Figure 3.5 Cosedimentation of exu protein and microtubules using detergent 
extracted ovary lysate. 
B . W e s t e r n blot ana lys i s tubul in . A dup l i ca t ed b lo t o f F i g u r e 3 . 5 A w a s de t ec t ed by an t i -P- tubu l in 
an t ibody . 
L a n e : tubul in , t ubu l in w a s run a longs ide as a m a r k e r ; P l - P 4 , S l - S 4 , 5，6，see F igu re 3.5 A. 
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3.6 Analysis of intracellular distribution of exu protein and 
Release of exu protein by sodium carbonate treatment for 
cosedimentation with microtubules 
As only low level of exu protein was extracted even in the presence of 
detergents, subcellular fractionation was used to analyze the subcellular distribution 
of exu protein. A sodium carbonate treatment was adopted to release exu protein 
from the microsomal fraction for the cosedimentation experiment. This treatment 
was found to be effectively removing ribosomes from endoplasmic reticulum 
membranes and converting sealed vesicles into flat membrane sheets, resulting in 
release of cisternal contents (Fujiki et al., 1982). Besides, this method was non-
destructive and had a higher efficiency in releasing proteins than normal low 
detergent conditions. Exu protein released by this treatment was used for 
cosedimentation experiment and the associations between exu and microtubules 
were verified by western blot analysis. 
3.6.1 Materials and Methods 
3.6.1.1 Subcellular fractionation of ovary extracts 
Ovaries were homogenized and fractionated according to the protocol for 
fractionation of liver (Evans, 1992) (Figure 3.6). The ovaries (about 100 pairs) 
were isolated from well-fed two-day-old flies in PBS. They were briefly washed in 
PM and resuspended in 1 ml of the same buffer. Using a tight-fit pestle, the ovaries 
were dounce-homogenized by 20 to 30 strokes on ice. All subsequent steps were 
performed at 4°C. The homogenate was first clarified by centrifugation at 1000 x g 
for 10 minutes in a JA-20 rotor in Beckman J-2 MC centrifuge. The supernatant 
was saved while the pellet was resuspended in 0.5 ml PM. The suspension was 
centrifuged once again and the pellet was collected as F1 fraction which contained 
mostly of large membranes and nuclei. The supernatant was pooled with the 
previous one and was centrifuged under the same conditions as above. This latter 
pellet, which contained very low amount of cellular components, was discarded. 
The supernatant was spun at 8,000 x g for 20 minutes and the resulting supernatant 
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was saved while the pellet was resuspended in 0.5 ml PM and was collected by 
centrifugation. The supernatant was pooled while the pellet was again resuspended 
and collected by centrifugation. The resulting pellet was referred as an F2 fraction 
which contained organelles such as lysosomes, mitochondria and peroxisomes. The 
supernatant was pooled and centrifuged at 100,000 x g for 1 hour in a TLA-120.2 
fixed angle rotor in Beckman Optima TLX Tabletop Ultracentrifuge. This final 
pellet was a microsomal fraction and was referred to as the F3 fraction. 
3.6.1.2 Release of contents from fractions by sodium carbonate treatment 
Three fractions, F1, F2 and F3 were collected as described above. Each 
fraction was divided into two portions: one was resuspended in 1 ml of 100 mM 
sodium carbonate (pH 11.5) while the other was resuspended in 1 ml of PM as a 
control. The sodium carbonate treatment converts closed vesicles to open 
membranes in the cellular fraction and releases their content proteins and peripheral 
membrane proteins (Fujiki et al., 1982). The suspensions were incubated for 30 
minutes at 4°C. Afler centrifugation at 230,000 x g for 1 hour at 4°C in the TLA-
120.2 rotor, both pellets and supernatants were saved for analysis. 
3.6.1.3 Cosedimentation of exu proteins with microtubules 
The supernatant from section 3.6.1.2 was dialyzed in 1 liter of PM buffer 
with 0.28 mM PMSF, 5 mM NaF, 100 uM Na3VO4 for 4 hours and repeated once 
with fresh buffer for 4 hours at 4°C. After dialysis, the extract was clarified by 
centrifugation at 78,000 r.p.m. in the Beckman TLA-120.2 rotor. 
The interactions between exu protein and microtubules was determined by 
the microtubules sedimentation protocol described by Arshad Desai (personal 
communication) and Walczak et al. (1996) with the following modifications. The 
extract was supplemented with protease inhibitors and 1 mM GTP and warmed to 
room temperature. The extracts was further supplemented with 20 uM taxol and 
then 0.2 mg/ml of taxol-stabilized microtubules and incubated for 20 minutes at 
30°C. The microtubules and microtubule associated proteins were collected by 
centrifugation on 1ml cushion of 40 % glycerol in PM buffer, containing 10 uM 
taxol, protease inhibitors and 5 mM NaF, 100 uM Na3VO4, at 42,000 r.p.m. for 30 
105 
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minutes at 30°C in a Beckman TLS-55 swinging bucket rotor. Both the pellets and 
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Figure 3.6 A diagrammatic representation of the subcellular 




3.6.2.1 Intracellular distribution of exu protein 
Brief homogenization process was unable to extract the exu protein from 
the ovary homogenate. Hence most of exu protein was lost during the clarification 
step in the methods in the previous sections. A more effective method was 
employed to release exu protein. As shown in Figure 3.7, most of exu protein was 
found in fraction F3, some was present in fraction F1, and little in fraction F2. The 
fraction F3, which was referred to as the microsomal fraction, contained mostly of 
cellular microsomes (Evans, 1992). 
Furthermore, the exu protein in fraction F3 was released into a soluble form 
after the Na2CO3 extraction. In the controls which were extracted with PM buffer, 
most of exu protein remained insoluble in the pellet (lane P-control) and little was 
released in the supernatant (lane S-control). On the contrary, much of the exu 
protein was released in the supernatant (lane S-Na2CO3) and only some remained in 
the pellet (lane P-Na2CO3) after the Na2CO3 treatment. The treatment of Na2CO3 
appeared to be able to release significant amount of exu protein. 
3.6.2.2 Cosedimentation of exu protein with microtubules using Na2CO3 
released extracts 
As shown in Figure 3.8A, most of the exu protein was found in the 
supernatants (lanes Sl-S4), where exu protein did not associate with microtubules. 
Although a comparatively larger amount of exu protein was extracted, there was 
only a very low level of exu protein cosedimented with microtubules. However, we 
still could not conclude that exu protein did not bind microtubules because the 
processes of sodium carbonate treatment and dialysis would possibly alter the 
biochemical properties of the proteins. The resulting exu protein would be modified 
and might have lost the ability to associate with microtubules. 
To determine i f microtubules were sedimented，microtubules were 
supplemented and so abundant tubulin was observed in the pellets (lanes P1 and P3, 
Figure 3.8B) while a low level was found in the supernatants (lanes S1 and S3). 
(Microtubules are polymerized form of tubulin subunits and they are depolymerized 
on SDS PAGE.) The presence of the tubulin band in supernatants was due to the 
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existence of the steady state at which the microtubules mass and the concentration 
of non-polymerized tubulin subunits remained constant (Bayley et al., 1994). As an 
equilibrium existed between tubulin subunits and microtubules, microtubules were 
not exclusively present in the pellets (lanes P1 and P3). On the contrary, a very low 
level of tubulin was found in the pellet (lane P4) and most remained in the 
supernatant (lane S4) as only unpolymerized tubulin subunits was added. In lanes 
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Figure 3.7 Subcellular fractionation of ovary extract. 
A m o u n t of exu prote in w a s de te rmined by wes te rn blot de tec t ing wi th an t i -exu an t ibody . 
M o s t of exu protein w a s associa ted wi th F3, the m i c r o s o m a l f rac t ion . S o d i u m ca rbona te 
t r ea tmen t re leased m o r e than half of the exu protein f r o m F3 whi le little w a s ext rac ted in the 
control us ing P M buf fe r . 
Lane : F l , subcel lu lar f rac t ion conta ined ma in ly large m e m b r a n e s and nuc le i ; F2, f rac t ion 
conta ined lysosomes , mi tochondr ia , and pe rox i somes ; F3 , m i c r o s o m a l fraction; F 4 , the 
superna tan t wi th little subcel lu lar componen t s ; P, S, pel lets and superna tan t s resu l t ing f rom 
sod ium carbona te t rea tment ; Na2CO3, f rac t ion extracted with sod ium ca rbona te ; control , 
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Figure 3.8 Analysis of exu protein and microtubules after 
cosedimentation using sodium carbonate released fraction. 
A f t e r s o d i u m c a r b o n a t e t r ea tmen t , m i c r o t u b u l e s w e r e incuba ted wi th the ex t rac t s and 
w e r e ana ly sed a f t e r co l lec t ion by c e n t r i f u g a t i o n . 
A . W e s t e r n blot ana lys i s o f e x u pro te in c o s e d i m e n t e d w i th m i c r o t u b u l e s . 
I L a n e : exu®^ w i l d t y p e , ova ry ex t rac t s f r o m exu^^ and the wi ld t y p e r e spec t ive ly ; P，S, 
pel le ts and supe rna tan t s resu l t ing f r o m incuba t ions of ; 1，wild t ype o v a r y ex t rac ts , G T P , 
taxol and m i c r o t u b u l e s ( M T ) ; 2, ex t rac ts , G T P , t axo l , no M T ; 3, G T P , taxol , M T , no 
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Figure 3.8 Analysis of exu protein and microtubules after 
cosedimentation using sodium carbonate released fraction. 
B . W e s t e r n blot ana lys i s o f tubu l in . A dup l i ca t ed b lo t o f F i g u r e 3 . 8 A w a s de tec ted 
by an t i -P - tubu l in an t ibody . 
L a n e : P, S; 1，2，3, 4, see F i g u r e 3.8 A . 
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3.7 Cosedimentation of exu protein and microtubules in high 
ATP concentration 
Conventional MAPs are selectively cosedimented with microtubules in the 
presence of high concentration of ATP, while both MAPs and motor proteins bind 
microtubules when ATP is depleted (Lee, 1989; Wiche, 1989; Rickard and Kreis, 
1991; Hays et al., 1994; Arshad Desai, personal communication). By providing a 
high ATP concentration, microtubules were pelleted and analyzed for the presence 
of exu protein. 
As exu protein was associated with the microsomal fraction, as described in 
the previous section, a more effective homogenization method was used. In 
addition, MAP-free phosphocellulose-purified tubulin was used as a source of 
microtubules. 
3.7.1 Materials and Methods 
3.7.1.1 Preparation of ovary extracts and microtubules sedimentation 
The following protocol was essentially as described by Walczak et al. (1996) 
and Arshad Desai (personal communication) with modifications. About 200 pairs of 
flies，ovaries were dissected in PBS. The ovaries were briefly washed in PM buffer 
containing protease inhibitors (1.0 ug/ml Pepstatin A, 1.0 ugAnl Leupeptin, 1.0 
ug/ml Aprotinin, 0.28 mM PMSF). The ovaries were dounce-homogenized at 4。C 
by 60 strokes using a tight-fit pestle. Further homogenization was done by 
sonication at 4°C with 15 times of 10 second-bursts. The homogenate was clarified 
by centrifugation at 78,000 r.p.m.(in a Beckman TLA-120.2 rotor) for 30 minutes 
at 4。C. 
The supernatant was supplemented with a final concentrations of 2 mM 
ATP and 1 mM GTP on ice and then warmed to room temperature. Taxol was 
added to 5 mM and incubated for 5 minutes at 30°C. Additional taxol was added to 
a final concentration of 20 mM. Taxol stabilized microtubules were polymerized 
from phosphocellulose-purified bovine tubulin and were added to a final 
concentration of 0.2 mg/ml. After incubation for 30 minutes at 30°C, the sample 
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was layered onto a 40 % glycerol cushion containing 0.5 mM GTP, 10 uM taxol 
and protease inhibitors. Microtubules were sedimented at 42,000 r.p.m. for 40 
minutes at 25°C in a Beckman TLS-55 swinging bucket rotor. The pellet was 
dissolved in I X SDS sample buffer while the supernatant was concentrated by 
acetone precipitation and then dissolved in SDS sample buffer. The samples were 
analyzed by SDS PAGE and western blot analysis as described in sections 2.3.1.2 
and2.3.1.3. 
3.7.1.2 Western blot using a chemiluminescent detection system 
For higher sensitivity, a chemiluminescent detection kit, Western Star™ 
(Tropix) was used. Following electroblotting, the blot was washed briefly with PBS 
and then was blocked in blocking buffer (0.4 % I-block, I X PBS, 0.1 % Tween 20) 
at 4°C overnight. The blot was either probed with the anti-exu antibody (dilution in 
1:1500) or the anti_P_tubulin antibody (0.25 ugAnl) diluted in blocking buffer for 2 
hours at room temperature. After washing three times for 15 minutes in wash buffer 
(PBS, 0.3 % Tween 20), the blot was incubated with alkaline phosphatase(AP)-
conjugated secondary antibodies for 2 hours at room temperature. An AP-
conjugated anti-rabbit antibody was used for detecting the anti-exu while an AP-
conjugated anti-mouse antibody was used for probing the anti-P-tubulin. The blot 
was washed three times for 15 minutes in wash buffer and then twice for 5 minutes 
in assay buffer (20 mM Tris-HCl, pH 9.8’ 1 mM MgCl2). After draining the excess 
assay buffer, the blot was flooded with 500 ^il of substrate solution (5 ^il CPD-star 
substrate, 25 ^il Nitro-Block II, 470 ^il assay buffer) and was then sandwiched in 




A more effective homogenization method was used for preparing the ovary 
extracts. The ovaries were homogenized with more extensive dounce-
homogenization and sonication resulting in release of higher amount of exu protein. 
As shown in Figure 3.9A, exu protein was found to cosediment with 
microtubules. A single band of exu protein was cosedimented wi th microtubules 
(lane P2) while no exu protein was sedimented in the absence of exogenous 
microtubules (lane P1). The wild type exu protein could be largely separated into 
four major bands or molecular weight isoforms on SDS PAGE. The band observed 
in lane P2 corresponded to the second band of exu protein when counting in an 
ascending order of relative molecular weight. It was interesting that only one of 
these major isoforms was cosedimented with microtubules whereas none of the 
other three isforms could be observed (lane P2). Therefore, the in vitro interaction 
between exu protein and microtubules was specific to only one of the isoforms. 
The experiment was repeated using a chemiluminescent detection kit for 
western blot analysis. This assay provided higher sensitivity for detecting low level 
of protein. In the presence of both the wild type ovary extract and exogenous 
microtubules (lane P1, Figure 3.10A), exu protein was shown to cosediment with 
microtubules, while no exu protein was observed in the controls that contained 
ovary extracts only (lane P2), microtubules only (lane P3), and both ovary extracts 
and tubulin (lane P4). Again, only a single band was found to cosedimented with 
microtubules and this band corresponded to the second molecular weight isoforms 
of the multi-phosphorylated exu protein. 
It was noteworthy that most of exu protein was not cosedimented with 
microtubules but remained unbound in the extracts. The amount of exu protein 
cosedimented with microtubules was relatively low in comparison with the total exu 
protein present in the ovary extracts. Several possibilities would account for this 
observation. The in vivo interactions between exu and microtubules might not have 
been reproduced well in an in vitro cosedimentation environment. Also, other 
components necessary for their interactions might not have been preserved. 
Therefore, a higher level of exu protein might have been associated with 
microtubules in vivo. Alternatively, it was possible that only a small proportion of 
； 1 1 5 
the total exu protein was needed for the interactions. Furthermore, as only the low 
molecular weight species interacted with microtubules, the hypo-phosphorylated 
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Figure 3.9 Cosedimentation of exu protein and microtubules in the 
presence of high ATP concentration. 
A . Western blot analysis of exu protein cosed imented with microtubules . 
Lane: exu^c’ wild type, ovary extracts f rom exz^'^and the wild type respect ively; P, S, 
pellets and supernatants result ing f rom incubat ions of; 1，wild type ovary extracts, GTP, 
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Figure 3.9 Cosedimentation of exu protein and microtubules in the 
presence of high ATP concentration. 
B . Wes te rn blot analys is o f tubul in . A dupl ica ted blot o f F igure 3 .9A w a s detec ted by 
ant i -P-tubuIin ant ibody. 
Lane: P, S, see F igure 3 .9A. 
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Figure 3.10 Dectection of cosedimentation of exu and microtubules 
j 
I in the presence of high ATP concentration by chemiluminescence blot 
A . W e s t e r n blot ana lys i s o f e x u p ro te in c o s e d i m e n t e d w i th m i c r o t u b u l e s . 
L a n e : exu®^ w i ld type , ova ry ex t rac t s f r o m exu% and the wi ld t y p e r e spec t ive ly ; P, S, 
pe l le ts and supe rna tan t s r esu l t ing f r o m incuba t ions of ; 1, wi ld t y p e ova ry ex t rac ts , G T P , 
taxol and m i c r o t u b u l e s ( M T ) ; 2，ovary ex t rac t s on ly , no M T ; 3，M T only , no ova ry 
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Figure 3.10 Dectection of cosedimentation of exu and microtubules in 
the presence of high ATP concentration by Chemiluminescence 
B . Wes t e rn blot analysis of tubul in . A dupl ica ted blot of F igure 3 .10A w a s de tec ted by 
ant i -p- tubul in ant ibody. 
Lane: see F igure 3 .10A. 
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Figure 3.10 Dectection of cosedimentation of exu and microtubules in 
the presence of high ATP concentration by Chemiluminescence 
C . Wes t e rn blot analys is o f exu protein cosed imen ted wi th mic ro tubu les . A duIpicated 
blot o f F i g u r e 3 .10A was m a d e by shor ter exposure t ime which r educed the backg round . 
Exu protein is indicated by the ar row. 
Lane: see F igure 3 .10A. 
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3.8 Discussion 
Localization of exu protein was found to be affected by the organization of 
microtubules. Using a microtubule destabilizing drug, colchicine, the localization of 
exu protein was completely abolished during oogenesis. Control injections with 1 % 
ethanol and with cytochalasin D confirmed that the localization was neither affected 
by the injection itself nor the stability of actin. Therefore, the localization of exu 
protein was sensitive to the organization of microtubules. When microtubules were 
destabilized, exu protein no longer localized in the oocytes from stages 1 through 9, 
indicating that exu protein requires an intact microtubule network for its 
localization and suggesting possible physical interactions between exu protein and 
microtubules. 
Several approaches were used to determine whether exu protein interacted 
with microtubules. In the first approach, exu protein was purified by 
immunoprecipitation and then was allowed to bind microtubules. However, this 
method was unable to determine the interactions because microtubules seemed to 
bind to the protein G-agarose non-specifically. 
Based on the observation of the dependence of localization of exu protein 
on microtubules, the cosedimentation approach that was used for isolation o fMAPs 
was adopted. Various conditions for MAPs cosedimentation were used but a major 
difficulty was encountered in which only a low concentration of exu protein was 
extracted in the ovary homogenate. The usual homogenization methods employed 
by other MAPs cosedimentation experiments seemed to be insufficient to extract 
exu protein as most of it was lost after clarification by centrifugation. Thus, the 
limitation of the amount of exu would in fact account for the low amount of exu 
protein cosedimented with microtubules in sections 3.4 and 3.5. 
By subcellular fractionation, it was found that the low concentration of exu 
in the ovary extracts was due to the association of exu to the microsomal fraction， 
which was lost during the clarification step. To release exu protein from the 
microsomal fraction, a more effective homogenization and sonication procedure 
was employed. Fortunately, more exu protein was extracted into the soluble 
fraction (section 3.7). About half of the total exu protein could be extracted and the 
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cosedimentation experiment was repeated with these extracts. Besides, 
phosphocellulose-purified bovine tubulin was used instead of rat tubulin as the 
former was the one usually used in MAPs sedimentation experiments. 
The experimental results showed that exu did cosediment wi th microtubules. 
Although only a small proportion of total exu protein bound microtubules, their in 
vitro association was specialized to only one molecular weight isoform which was 
hypo-phosphorylated. Thus the interaction between exu protein and microtubules 
appeared to be very specific. 
The experimental results shown here extended the model proposed by Lane 
and Kalderon (1994), in which exu protein may play a role similar to that o fMAPs. 
At the beginning of mid-oogenesis (stages 6-7), the posteriorly located MTOC 
degenerates and the new microtubules nucleating region establishes at the anterior 
of the oocyte providing a uniform gradient necessary for the correct localization of 
maternal determinants (Theurkauf, et al. 1992, 1993). The degeneration of the 
posterior MTOC has been shown to depend on a germline protein kinase A (PKA) 
as mutations of PKA resulted in the persistence of the posterior MTOC at mid-
oogenesis (Lane and Kalderon, 1994). It was proposed that the germline PKA is 
activated by signals generated from the posterior polar follicle cells which in turn 
destabilizes the posterior MTOC (Lane and Kalderon, 1994). A MAP2-like protein 
was thought to bridge between PKA and microtubules MTOC (Lane and Kalderon, 
1994). MAP2 has been shown to be phosphorylated by PKA in vertebrate brain 
extract (Sloboda et al., 1975; Theurkauf and Vallee, 1982). Furthermore, it can 
stabilize microtubules by their associations, and this stabilizing effect can be 
released by PKA phosphorylation o f M A P 2 (Jameson and Caplow, 1981). The 
posterior MTOC is likely to be stabilized by binding of the MAP2-like protein at 
the early oocytes (stages 2-6). At the beginning of mid-oogenesis (stage 6), the 
MAP2-like protein may be phosphorylated by PKA and dissociated from 
microtubules which lose the stabilization and thus the posterior MTOC degenerates. 
As the experimental results shown here suggested that exu was a MAP, it 
might function to regulate the stability of microtubules. It has been shown that exu 
protein was localized exclusively in the oocyte at very early stages of oogenesis, and 
this localization might facilitate its phosphorylation by PKA and its interactions with 
microtubules within the oocyte. As only a small amount of exu protein interacted 
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with microtubules, exu protein could not be associated with the whole population of 
microtubules but rather only with particular structures such as the nucleating 
centers o f microtubules or MTOC. MTOC is composed of a ring shaped complexes 
containing y-tubulin as well as several other proteins and plays a central role in 
regulating microtubule assembly (Moritz et al., 1995; Zheng et al., 1995; reviewed 
by Oakley, 1995). Thus exu protein may take part in the ring shaped complex to 
stabilize the MTOC. 
Besides, exu is a phosphoprotein which exists in multi-phosphorylated 
isoforms and exu from the ovary extracts could be phosphorylated by several 
specific protein kinases, including PKA (Cheung et al., unpublished data, 
manuscript in preparation). The specific interaction between one of the hypo-
phosphorylated isoforms of exu protein and microtubules suggested that exu might 
be involved in the regulation of stability o f M T O C by its phosphorylation. 
Although exu protein is shown here to interact with microtubules, it would 
be interesting to determine i f there are interactions between exu and MTOC. 
Further studies may involve a cytological and genetic approach to analyze the 
distribution of MTOC within egg chambers o f exu mutants. An abnormal 
distribution o f M T O C wil l be observed in the exu mutants i f exu protein is involved 
in regulating the stability o fMTOC. In addition, analysis of distribution of both exu 
protein and MTOC within egg chambers may reveal their in vivo interactions. 
Immunohistochemical staining can be used to analyze the distribution of exu protein 
and y-tubulin, which is one of the components of MTOC. I f exu protein interacts 
with MTOC, they wi l l be expected to colocalize within the egg chambers. 
Furthermore, egg chambers of the PKA mutants, which have abnormal distribution 
of MTOC at both ends of the oocyte, can be examined in parallel with those of the 
wild type to determine i f exu protein is always colocalized with MTOC. Another 
studies may involve a biochemical approach to analyze the interactions between exu 
and MTOC. MTOC can be purified according to the protocol described by Zheng et 




Although the deletion analysis did not identify the functional domains ofexu 
protein, it had restricted the potential functional regions by determining the 
dispensability of 62 amino acid residues at the C-terminus. 
Luk et al. (1994) has demonstrated the existence ofconservation in the exu 
coding sequence among different Drosophila species. There are several conserved 
regions found within the coding sequences of the three evolutionary diverged 
species, D. melanogaster, D. virilis and D. pseudoobscura. Two highly conserved 
regions，one locating near the N-terminus with greater than 90 % of homology and 
one locating in the middle of the coding sequence with almost 100 % homology, 
were observed among the three species. Other three regions with intermediate 
sequence conservation were also found and PEST domains were located within one 
of these regions. 
Functionally important domains of a protein usually have high structural 
restraints and they are conserved, at least at the amino acid sequence level, among 
homologues of different species. Thus fonctional domains are expected to reside 
within the conserved regions of the exu protein coding sequence. Deletion analysis 
within the conserved regions wi l l presumably locate the functional domains ofexu. 
As exu protein has been proven to bind microtubules in vitro, it is now 
possible to delineate the interacting domain(s) of exu protein. Deletion analysis wil l 
be performed to analyze the potentially important regions on the coding sequence. 
Taking advantage of the existing deletion mutants, mutant exu proteins prepared 
from each mutant can be used for cosedimentation assay to further identify the 




1. SDS PAGE 
Part I GeI setup 
The gel unit of thickness 0.8 mm was assembled and sealed with tape at the 
bottom. A 10 % gel mix was prepared according to Table A l . A gel plug was made 
by mixing 2 ml of the above gel mix with 16.5 ^il 20 % ammonium persulphate and 
6.5 ^il TEMED. This gel mix was thoroughly mixed and pipetted into the gel set. 
The gel plug was quickly polymerized and set within 5 minutes. After adding 33.5 
^d 20 % ammonium persulphate and 13.5 ^il TEMED, the remaining 10 % gel mix 
was thoroughly mixed and pipetted into the gel set. A thin layer of water was 
overlaid on the gel to avoid direct contact with air. The gel was then allowed to 
polymerize overnight. 
A stacking gel mix was prepared according to Table A2. The stacking gel 
mix was mixed with 35 ^d 20 % ammonium phosphate and 15 ^il TEMED and 
pipetted into the gel set. A comb was inserted and the gel was polymerized for 45 
minutes. 
Part HEIectrophoresis 
Protein samples were loaded into each wells and equal amounts of I X SB 
were loaded into the empty wells. Electrophoresis was run under a constant current 
of 25 mA for about 4 hours. 
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Table A1 Composition of separating geI 
5 % 8 % 10 % 12.5 % 15 % 20 % 
Tris-HCl，1.5 M (pH 8 . 8 ) ~ ~ 4 . 9 9 m l ~ ~ 4 . 9 9 ml 4.99 ml 4.99 m l ~ ~ 4 . 9 9 ml 4.99 ml 
Actylamide, 30 % 3.34 ml 5.34 ml 6.67 ml 8.34 ml 10.00 ml 13.34 ml 
SDS, 20 % 0.10 ml 0.10 ml 0.10 ml 0.10 ml 0.10 ml 0.10 ml 
water, double-distilled 11.57 ml 9.57 ml 8.24 ml 6.57 ml 4.91 ml 1.57 ml 
Table A2 Composition of stacking geI 
T% 
Tris-HCl, 0.5 M (pH 6.8) 2.5 ml 
Actylamide，3 0 % 1.7 ml 
SDS, 20 % 0 . 1 m l 
water, double-distilled 5.7 ml 
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2. Western blot analysis 
The gel together with a nitrocellulose paper (Schleicher & Schudl) pre-
wetted with water, were soaked in transfer buffer (2.91 g Tris, 1.47 g glycine, 1.9 
ml 10 % SDS, 100 ml methanol, make up to 500 ml with double distilled water) for 
15 to 30 minutes. The gel and the nitrocellulose were sandwiched in Whatman 
3MM paper, that have been presoaked with transfer buffer. This sandwich was 
placed on a semi-dry blot apparatus (Owl) and excess buffer was removed. The 
proteins of the SDS gel were transferred electrophoretically under a constant 
voltage o f l 5 V for 45 minutes. 
At the end oftransfer, the nitrocellulose blot was briefly washed in double-
distilled water and then blocked in 5 % (w/v) skimmed milk in TTBS (10 mM Tris-
HCl，pH 7.5，0.9 % NaCl, 0.05 % Tween 20) for 1 hour at room temperature. After 
blocking, the skimmed milk solution was replaced by a primary antibody diluted in 
TTBS with 1 % BSA. For the detection of exu protein, a rabbit anti-exu antibody 
was used in a dilution of 1 : 1000. After an overnight incubation at 4。C，the blot 
was washed three times for 15 minutes in TTBS. The blot was incubated with a 
goat anti-rabbit antibody conjugated with alkaline phosphatase, used at a dilution of 
1 : 5000 in TTBS with 1% BSA, for 2 hours at room temperature. The blot was 
washed three times for 10 minutes and then developed with NBT (0.033 % w/v) 
and B O T (0.017 % w/v) in AP buffer (100 mM Tris-HCl, pH 9.5，100 mM NaCl, 
50 mM MgCl2). The reaction was stopped by rinsing the blot with water. 
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3. Preparation of DNA template for DIG-labeling 
The plasmid (p l l 22 ) containing the bcd cDNA clone was digested with 
EcoRI and EcoRV to release a 1.7 kb fragment for the synthesis of a DNA probe. 
The following components were mixed in a microfuge tube and incubated overnight 
at 37°C: 
(1) double distilled water 12.6 ^il 
(2) NEB buffer for EcoRI 2.0 pil 
( 3 )BSA( lOX, NEB) 2.0^d 
(4 )2^ ig DNA (p l l22) 2.4^il 
(5) EcoRI (20 U/^il, NEB) 0.5 ^il 
(6) EcoRV (20 U/^il, NEB) 0.5 \i\ 
The digested DNA was mixed with 2 ^il of 6X gel-loading buffer (0.25 % 
bromophenol blue, 0.25 % xylene cyanol FF, 30 % glycerol in water, Sambrook et. 
al., 1989) and separated by electrophoresis on a 1 % agarose gel containing 0.5 
ug/ml of ethidium bromide for one hour (or until the dye front reached the end of 
gel) at a constant voltage of 100V. Using a hand-held U V lamp (long wavelength), 
the 1.7 kb-EcoRI/ RV fragment was located and excised. The gel piece was placed 
in a dialysis tubing and the DNA was recovered by electroelution (Sambrook et. al., 
1989). 
The eluted DNA was. purified through phenol/ choroform extraction and 
then precipitated by ethanol precipitation (Shapiro, 1981). One-tenth volume o f3 
M sodium acetate (pH 5.2) and two volumes of ice-cold absolute ethanol were 
added. The DNA was precipitated at -20°C for one hour. The precipitated DNA 
was collected by centrifugation at 10,000 x g for 15 minutes. The pellet was washed 
with 70 % ethanol and once again collected by centrifugation. The DNA pellet was 
air-dried for 5 minutes and then resuspended in 10 ^il ofdouble-distilled water. This 
DNA would be used as the template for DIG-labeling. 
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4. Test of labeling efficiency of DIG-IabeIed DNA probe 
The efficiency of the labeling reaction was tested by immobilizing the probe 
on nitrocellulose paper, detecting with an anti-DIG antibody and NBT / X-
phosphate color reaction as described below. 
A small amount of probe (1 ^il) was boiled in 5 ^il 5X SSC (20X stock: 3 M 
NaCl, 0.3 M sodium citrate, adjust pH to 7.0 with 10 N NaOH) for 5 minutes. In 
addition, a DIG-labeled DNA and an unlabelled DNA from the kit were also boiled 
to serve as the positive control and negative control respectively They were then 
quickly chilled on ice and 1 ^il of the content was spotted onto a small strip of 
nitrocellulose paper. The spots were air-dried and cross-linked by U V using a UV 
Stratalinker 1800. The nitrocellulose strip was wetted with 2X SSC and washed 
twice in PBT (PBS, 0.1 % BSA, 0.2 % Triton X-100). It was then incubated with 
an alkaline-phosphatase conjugated anti-DIG antibody (Boehringer) in PBT for 30 
minutes. After washing twice in AP buffer, the reaction was developed with NBT 
(0.45 % v/v) and X-phosphate (0.3 % v/v) in AP buffer with 0.1 % Tween 20. The 
reaction was stopped by washing several times in PBS. The efficiency of the 
labeling reaction was determined by the intensity of the color spot produced by the 




ATP (0.1 M) 
0.1 M ATP was made by dissolving 60 mg of ATP (Sigma, disodium salt) in 
0.8 ml double-distilled water and the pH was adjusted to 7.0 with 1 N NaOH. The 
volume was adjusted to 1 ml and stored in aliquots at -70。C. 
BCEP 
0.5 g o f B O T (Sigma) was dissolved in 10 ml of 100 % dimethylformamide 
and the solution was stored at -20°C. 
DTT (1 M) 
3.09 g o fDTT (Pharmacia)was dissolved in 20 ml of 0.01 M sodium acetate 
(pH 5.2) and the solution was stored at -20°C. 
EDTA (0.5 M) 
18.61 g EDTA (BDH, disodium salt)was dissolved in 80 ml double-distilled 
water and the pH was adjusted to 8.0 with NaOH. The resulting solution was 
adjusted to 100 ml and sterilized by autoclaving. 
EGTA (100 mM) 
3.8 g of EGTA (Sigma) was dissolved in 80 ml double-distilled water and 
the pH was adjusted to 11 with NaOH. After dissolving all EGTA, the pH was 
adjusted to 8.0 and the solution at 4。C for use for one month. 
Electrode buffer (lOX) 
30.3 g ofTris base (USB) and 142.7 g of glycine (USB) were dissolved in 
1000 ml double-distilled water. 
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GMM 
25 ml of Canada Balsam (Sigma) was mixed with 1.7 ml methyl salicylate 
(Sigma) with agitation overnight. 
GTP (0.1 M) 
0.1 M GTP was made by dissolving 61 mg of GTP (3 moles o f N a and 1 
mole ofH2O per mole of GTP) (Sigma, Type I I I ) in 0.8 ml double-distilled water 
and the pH was adjusted to 7.0 with 1 N NaOH. The volume was adjusted to 1 ml 
and stored in aliquots at -70°C. 
Heparin 
Heparin (Sigma, sodium salt) was dissolved in 4X SSC at a concentration of 
50 mg/ml and stored at 4°C. 
NBT 
0.5 g o f N B T (Sigma) was dissolved in 10 ml of 70 % dimethylformamide 
and the solution was stored at -20°C. 
4 % paraformaldehyde 
0.4 g of paraformaldehyde (Fluka Chemica) was dissolved in 10 ml PBS and 
the solubility was increased by addition of 10 ^il 10 N NaOH and heating to about 
60°C. The solution was neutralized with 20 jul of 5 N HC1 and after cooling to 
room temperature. 
PIPES (1.0 M) 
30.24 g ofPIPES (FW 302.36) (BDH) was dissolved in 80 ml of double-
distilled water and the pH was adjusted to 6.8 with NaOH. (PEPES would gradually 
dissolved as pH increased.) The solution was adjusted to 100 ml. 
Proteinase inhibitors 
aprotinin (Sigma) - stock solution of 10 mg/ml was made by dissolving in 
0.01 M HEPES (pH 8.0) and stored at 4°C. 
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leupeptin (Sigma)- stock solution of 10 mgAnl was made by dissolving 
double-distilled water and stored at 4°C. 
pepstatin A (Sigma)- stock solution of 1 mg/ml was made by dissolving in 
methanol and stored at 4°C. 
PMSF (Sigma)- Stock solution of 200 mM was made by dissolving in 
ethanol and stored at 4°C. 
Sonicated salmon sperm DNA 
Salmon sperm DNA (Sigma, sodium salt)was dissolved in water at a 
concentration of 10 mgAnl. The concentration ofNaCl was adjusted to 0.1 M and 
the solution was extracted with phenol chloroform. The DNA solution was 
sonicated and precipitated by adding 2 volumes of ice-cold ethanol. The DNA was 
dissolved in double-distilled water and the exact concentration was determined by 
OD260-
SSC (20X) 
175.3 g o fNaCl and 88.2 g of sodium citrate were dissolved in 800 ml 
double-distilled water and the pH was adjusted to 7.0 with NaOH. The final volume 
was adjusted to 1000 ml and the solution was sterilized by autoclaving. 
Transfer buffer 
2.91 g Tris base, 1.47 g glycine, 1.9 ml 10 % SDS and 100 ml methanol 
were mixed and adjusted to 500 ml with double-distilled water. 
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